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Metalloenzymes are incredibly complex “machines” which catalyze reactions 
essential for life. Metal ions are found in more than half of all known proteins; 
particularly, copper and iron are abundant in active sites performing complex reactions. 
The coordination environment around the metal center itself drives the metal ion to 
undergo biospecific, highly optimized, and selective reactions, such as the oxidation of 
methane to methanol, splitting of water, or generation of ammonia. Most of the active 
sites are asymmetric and some metal ions are forced into strained geometries. These 
factors facilitate catalysis and electronic tuning. Against this background, aspects of 
strain and asymmetry were probed in model complexes with iron and copper ions. 
Utilizing Schiff base ligands as molecules that can be easily manipulated in steric and 
electronic properties via building block assembly, iron and copper complexes were 
synthesized.  







[(FeL)2(µ-O)] (L = 2,2'-(2-Methyl-2-(pyridin-2-yl)propane-1,3-diyl)bis(azanediyl)- 
bis(methylene)- diphenolate and L
NO2
 = 2,2'-(2-Methyl-2-(pyridin-2-yl)propane-1,3-diyl 
bis(azanediyl)- bis(methylene)bis(4-nitrophenolate)) show structural and spectroscopic 
similarities to bridged hydr(oxo)diiron containing active sites of metalloproteins. 
Unique properties of the ligand create asymmetry of the diiron unit as well as bent Fe–
O–Fe structures. The stability of the bio-relevant mixed-valence state was investigated 
by electrochemical means, as well as by chemical reduction. Unfortunately, the 
Fe(II)/Fe(III) state is not accessible in the complex presented here. However, a 
mechanistic pathway of decomposition is suggested and an interesting feature of the 
xxv 
ligand used in this study may allow for stabilization and characterization of the mixed-
valence state, and even further, it may reveal the role of a unique amino acid residue 
interaction with the diiron site in rubrerythrin. 
Two copper(II) complexes (dimeric [Cu(HL
2
)]2(ClO4)4 and monomeric 
[Cu(L
3
)](ClO4)2) with novel, related Schiff base ligands (HL
2
 = 2-((2-Methyl-2-








synthesized and characterized. One series of studies revealed a synthesis plan for 
asymmetric Schiff base complexes through unique properties of the ligand. It was 
shown that intermediate electronic tuning of the copper(II) complex is possible in the 
asymmetric complex compared to the fully symmetric analogues.  











bissalicylidene-4,16-diamino[2.2]paracyclophane) which were obtained in this study are 
reminiscent of blue copper protein centers which allow for fast electron transfer by 
having geometries between tetrahedral and square planar. Structural and spectroscopic 
studies show that strain is present in both the solid and solution state. The distortion 
causes a shift in redox potential of about half a volt compared to square planar 
analogues. Initial studies revealed that strained complexes with other divalent metal 
ions are possible to form (e.g. [CoL
5-gem
] was isolated and characterized). Strained 


















1.1 Bioinorganic Chemistry 
Life as we know it would not be possible without metal ions; about half of all 
the proteins contain metals [1]. Particularly, transition metals play a big role in 
metabolic processes, which are essential for life [2-4]. Compared to other metals found 
in metalloproteins like Mn, Mo, Ni, Co and Zn, Fe and Cu are by far the most common 
metal ions found in proteins. This is not surprising because iron and copper are 
particularly abundant in nature and this probably led to evolution of natural systems 
with these two metals. Iron is by far the most abundant transition metal in vivo 
averaging 60 mg/kg of body weight (about 75% of the iron is bound in hemoglobin) [5]. 
Copper on the other hand is considered a trace element, and about 150 mg are found in 
an adult human body [5].  
In the first part of this chapter the reader will be given a broad overview of the 
role of metals in biological systems and the great diversity of different functions in vivo. 
Then the idea behind mimicking bioinorganic systems will be explained. Some 
examples of the state-of-the-art model chemistry will be shown. Finally, the background 
for the three projects of this dissertation will be introduced, which will lead into the 
individual project goals. 
Bioinorganic chemistry is the science of metal species in biology. In this 
dissertation, the focus lies on metalloproteins and metalloenzymes. Metalloproteins are 
proteins which contain a metal center but do not catalyze a chemical reaction; examples 
are dioxygen carrying proteins [6] (e.g. hemerythrin, hemoglobin and hemocyanin), 
electron transfer proteins [7] (e.g. rubredoxin, plastocyanin) or metal ion 
storage/transfer proteins [8] (e.g. siderophores, ferritin). Metalloenzymes on the other 
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hand are biological units which perform catalytic reactions at a metal site. Some 
important catalytic reactions are given below, and different metal sites, with one 
example for each of several transition metal ions, are chosen to emphasize the diversity 
of biological systems. Molybdenum is found in nitrogenases, which are capable of 
nitrogen fixation [9], manganese is involved in the splitting of water (oxygen evolving 
complex in photosystem II) [10], iron plays a role in the oxidation of methane to 
methanol in soluble methane monooxygenase [11], cobalt is found in the active site of 
cobalamin and is involved in the metabolism of every cell [12], copper occupies the 
active site in nitrous oxide reductase and catalyzes the conversion of N2O to molecular 
nitrogen as the last step in denitrification [13], zinc is found in superoxide dismutase, an 
enzyme which catalyzes the disproportionation of superoxide to hydrogen peroxide and 
dioxygen [14], nickel is part of the active site in hydrogenase, which catalyzes the 
reversible oxidation of dihydrogen [15].  
When looking at a given metal ion, once placed into the proper (evolved) 
coordination environment in organisms, the metal ion will have a highly specialized 
function, acting as a specific bio-catalyst. Distinct environments and/or geometries and 
the oxidation state of the metal ion result in a different function of the active site. For 
example when looking at copper, this metal ion acts as an electron relay shuttling 
between Cu(II) and Cu(I) in electron transfer proteins such as blue copper proteins [16]. 
In different sites, it binds O2 reversibly (e.g. in hemocyanin [6]), or activates dioxygen 
[17-19]. A subsequent reaction of the oxygen (oxidase, mono- and dioxygenase-like 
activity) can be observed. In oxidases the O-atom is not actually transferred onto a 
substrate but rather acts as an oxidizing agent (electron acceptor). O2 is then converted 
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to either hydrogen peroxide (2e
–
 redox process) or water (4e
–
 redox process). An 
example for an oxidase is laccase, which is found in higher plants and fungi; it is 
involved in cell wall formation [20]. If the active site has mono- or dioxygenase 
activity, one or both O-atoms, respectively are added onto a substrate. Tyrosinase, a 
monooxygenase, catalyzes the hydroxylation of monophenols to o-diphenols, and 
therefore is involved in the initial step of L-DOPA biosynthesis [21]. Flavonol 2,4-
dioxygenase, a dioxygenase, is an enzyme which catalyzes oxidative C–C bond 
cleavage [22]. 
On the other hand, it is also possible that different metal ions fulfill the same 
function and selected examples will be discussed below. The iron or copper metal 
center can function as an electron relay and therefore act as a redox mediator. Proper 
coordination environment will influence the redox potential of the metal ion [23]. In 
photosynthesis, ferredoxin, an iron-sulfur cluster [24], as well as blue copper proteins 
[25], play an important role as electron mediators for fast electron transfer processes.   
The in vivo transport of dioxygen, for most organisms, requires the interaction of 
copper or iron with O2. In vertebrates, hemoglobin, a heme-based iron complex, is 
responsible for reversibly binding dioxygen, while organisms like marine invertebrates 
use hemerythrin and mollusks use hemocyanin, a non-heme diiron and a dicopper site, 
respectively [26].  
Methanotrophic bacteria, which are capable of oxidizing methane to methanol, show 
two active enzymes, particulate and soluble methane monooxygenase (pMMO and 
sMMO). Under normal conditions, pMMO is expressed [27], which is believed to be 
copper based. However, in the event of copper deficit, iron can be used and the well- 
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characterized iron based enzyme, sMMO, is expressed which catalyzes the same 
reaction. Active sites of a variety of copper and iron proteins will be discussed in more 
detail in Chapters 2-4. 
Thus far, active sites containing different metals have been described. However, the 
complexity of biological systems deserves mentioning as well. First, the advantage of a 
protein environment around the active site will be explained, followed by an example of 
more complex protein-protein interactions. A cartoon is shown in Figure 1.1 and should 
simplify the complexity of proteins. In blue is shown a metalloenzyme with its active 
metal site imbedded (red). Several channels are depicted, a green channel for substrate 
intake and a blue one for product transport. Most proteins also have some kind of chain 
mechanism for electron transfer, commonly found are iron sulfur clusters which act as 
electron mediators (purple). The yellow structure symbolizes a regulatory protein which 
can close a different substrate channel (depicted in black) upon association with the 




Figure 1.1. Cartoon which simplifies the complexity of a protein. Light blue: 
metalloenzyme; red: active site (containing a metal center = M) which is embedded in 
the protein; green: substrate channel (S = substrate); dark blue: product channel (P = 
product); purple: electron transfer chain (Fe/S = iron-sulfur cluster, e
–
 = electrons); 
yellow: regulatory protein which can cut off a channel entrance for a substrate (black). 
  
The protein environment protects the active site and at the same time allows for 
selective substrate delivery and transport of the products away from the catalytic center. 
Some enzymatic sites cycle through high valent metal-oxo intermediates [28, 29], 
which are very reactive. In order to keep unwanted substrates away from getting 
oxidized, including the protein itself, and also to not quench the active species 
prematurely, it has to be “shielded” and only specific channels and their polarities allow 
for selected substrate diffusion and proton or electron transfer to the active site [30-32]. 
Proton shuttling and e-transfer within the protein have been studied recently in 
hydrogenase [33]. 
The enzyme sMMO, which is particularly interesting for scientists as it catalyzes 
remarkably the oxidation of methane, is chosen as an example for the importance of 
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protein-protein interactions. sMMO, which is a multicomponent monooxygenase, 
contains a regulatory protein (MMOB), the hydroxylase component, which hosts the 
active diiron core (MMOH), and a reductase (MMOR), which provides the source of 
electrons. Recently the Lippard group has investigated the interaction of MMOB with 
MMOH [34]. They report that binding of MMOB to MMOH closes pores which 
regulate the transport of dioxygen, methane, as well as protons, to the active site. This is 
an excellent example of the communication between two subunits, which allows for 
controlled oxidation and the addition of exact equivalents of electrons, protons and 
substrates to efficiently oxidize methane.  
Bioinorganic chemistry is an interdisciplinary field for biochemists, 
coordination chemists and spectroscopists. Scientists either study the properties of metal 
containing natural systems or they mimic the structure or function of it. The goal of this 
research is to understand how natural systems work by studying the isolated natural 
system or by artificial mimicry to understand structure-function relationships. Since it is 
generally impractical to isolate enzymes and use them to perform reactions on a large 
scale, the ultimate goal is to construct rather simple artificial systems that perform 
catalysis reactions on industrial scale, comparable to metalloenzymes. Particularly 
important is C–H activation catalysis and harvesting of visible light for energy 
generation. Rather than trying to mimic entire complex natural systems, it is important 
to first understand smaller concepts, such as: Why do metal ion complexes have specific 
coordination geometries? How does the type of donor (e.g. N vs. O atom) influence the 
properties of the metal ion? Why do dimetallic centers have particular bridging units 
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(e.g. O vs. OH, carboxylate)? The next section will explore the idea behind bioinorganic 
mimicry and the difficulties associated with it. 
 
1.2 Bioinorganic Modeling 
Metal centers in biology are ligated by amino acid residues which hold the metal 
ion in distinct positions. The kind and number of ligands create a specific coordination 
geometry and give the metal center unique properties. Some of the important “bio-
ligands” (including their donor functional group) are tyrosine (phenolate), histidine 
(imidazole), aspartate/glutamate (both carboxylate), cysteine (thiolate) and methionine 
(thioether), where typically the O, N, or S are donor atoms, which coordinate to the 
metal ion. Bioinorganic chemists try to isolate enzymes and structurally and 
spectroscopically characterize the active site in order to understand reactivity. 
Unfortunately, enzymes are difficult to purify while leaving their active sites intact, and 
even if successfully purified, the amounts of isolated enzymes are extremely small. The 
other problem in purification is the contamination of the active site by use of buffers 
where the native active structures can lose the original metal ion and bind different 
metal ions which were used during purification steps. Therefore, bioinorganic mimicry 
of active sites represents a major, important research field where active sites are 
synthetically generated. The active site is structurally mimicked and tested for reactivity 
to gain an understanding of structure-to-function relationships. If a model complex 
shows similar spectroscopic properties to an enzyme, it is very likely that both have 
similar structural features. Synthetic models are typically generated with the use of 
ligands, which are small organic molecules that have multiple donor atoms and mimic 
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distinct coordination geometries around the metal ion. By using model complexes and 
varying their substructures, one can sometimes understand why certain structural motifs 
in the natural active sites are important [3]. Despite the complexity of the protein 
environment, nature’s active sites themselves are commonly asymmetric and great 
activity in the metal ion is achieved through strain, which causes pre-organization 
towards the transition state. The aspects of strain and asymmetry are discussed in later 
chapters. 
In the following, an overview of popular ligands used in model chemistry will 
be given. The following figure shows tri- (first row), tetra- (second row) and 
pentadentate (third row) ligands. Probably most widely used are the ligands Me3TACN, 
TPA, TMC and various porphyrin derivatives. Some references, where these ligands 
were used to answer bioinorganic chemistry related questions are given in the figure 
caption of Figure 1.2. 
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Figure 1.2. Examples of ligands used in bioinorganic model chemistry. TACN = 
triazacylononane [35]; PMDT = pentamethyldiethylenetriamine [36]; Tpm = 
tris(pyrazolyl)methane [37]; TPA = tris(2-pyridylmethyl)amine [38]; TMC = N-
tetramethylcyclam [39]; Porphyrin-derivatives = porphyrins are usually substituted [40]; 
PyN4 = and derivatives [41, 42]; Py5Me2 = 2,6-bis(1,1-bis(2-pyridyl)ethyl)pyridine [43]. 
 
 There are several types of modeling; broken up into structural, functional and 
spectroscopical modeling. In structural modeling, scientists try to exactly remodel the 
active site with respect to coordination geometry and similarity in donors. An 
impressive example is given by the group of Agapie. They were able to build a 
structural model for the oxygen evolving complex, a manganese cluster, and with that 





Figure 1. 3. a) Molecular structure of the oxygen evolving complex (O shown in red, 
Mn shown in purple and Ca shown in teal. b) Schematic depiction of the Mn4O5Ca 
cluster. c) Schematic depiction of the model complex by Agapie. Figure is adapted from 
reference [44]. 
 
 The manganese cluster is the active site in photosystem II and catalyzes the 
splitting of water into dioxygen with release of four equivalents of protons and electrons 
(see Figure 1.3 a and b). The model complex (Figure 1.3 c) allowed for variation of the 
non-manganese ion within the cluster. Their studies revealed the role of calcium, which 
is crucial for the native enzyme in order to function properly, in the model complex. 
When calcium is replaced by other metal ions, such as sodium, strontium, zinc or 
yttrium, the redox properties of the cluster change [45].  
 An example for functional modeling is the work done by Meyer and coworkers 
[46]. They synthesized a diiron complex (see Figure 1.4 (right)), which mimics certain 
properties of Rieske proteins. Rieske centers contain a [2Fe-2S] cluster, which is 
involved in electron transfer reactions. Even though the model complex does not mimic 
the structure of the natural site it behaves very similarly. Figure 1.4 shows a schematic 
depiction of the Rieske center and the structure of the model compound for comparison. 
Meyer’s group revealed that the model complex shows a shift in redox potential upon 
protonation and undergoes proton-coupled electron transfer, just like the natural site. 
a b c 
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Figure 1.4. Schematic structure of the active site in Rieske proteins (left) and the model 
complex by Meyer (right). 
 
Finally, an example of spectroscopical modeling will be given. Houser et al. 
[47] have modeled CuA, a copper site which is responsible for transfering electrons 
during turnover of nitrous oxide reductase and cytochrome c oxidase. Figure 1.5 shows 
the structures of the natural site of CuA and the model complex for comparison. Again, 
the structures are comparable, but the donor atoms are different. As evidenced by EPR 




) state of the 
resting-state of CuA. Both cores give a seven-line hyperfine coupling pattern which is 






Figure 1.5. Structure of the active site in CuA (left) and model complex 
synthesized by Houser et al. (right). 
 
A few examples of active site mimicry were given and structural, functional as 
well as spectroscopic modeling was explained. While all these studies are important to 
gain further understanding of the active site in metalloproteins, progress is under way to 
take model chemistry to the next level of complexity. One excellent example of a highly 
engineered model complex is presented by the group of Chan [48]. A functional 
inorganic complex with a “protective capsule” similar to the protective environment in 
proteins, has been synthesized. The complex is able to oxidize methane to methanol. It 
has been speculated that pMMO may contain a tricopper cluster in the active site. With 
that inspiration the authors have made the tricopper complex shown in Figure 1.6. The 
active species is believed to be a [Cu(II)Cu(II)(μ-O)2Cu(III)] cluster, created upon 





Figure 1.6. Ligand used in the model study by Chang (left) and computed 
structure of the tricopper cluster [Cu(II)Cu(II)(μ-O)2Cu(III)] (nitrogen in blue; copper in 
dark red; oxygen in light red) with space filling model (right). Right side of figure is 
adapted from reference [48]. 
 
1.3 Previous Studies 
The ligands shown in Figure 1.2 as well as those used in the model examples are 
rather complicated to synthesize and variations of them (meaning sterically or 
electronically changed) are not easily obtained. Keeping synthetic ligands simple allows 
for efficient synthesis with only a few steps. Schiff base ligands are fairly easily 
obtained upon condensation of an amine with an aldehyde. Both the amino unit and the 
aldehyde can be varied and allow for building block variations, which results in diverse 
variation of the final ligand (see Chapter 3 for an expanded discussion of Schiff base 
ligands). The synthesis of asymmetric ligands is definitely more complicated, but there 
are some procedures that can be applied (see Chapter 3). Ligands can also be varied by 
addition of steric groups to protect certain sites around the metal ion. Strain can be 
generated by the use of double bonds or incorporation of strain-inducing linkers. 
Electronic changes can also be made by substitution of non-coordinating residues. In 
this thesis the induction of strain and asymmetry, electronic tuning and some concepts 
of asymmetric synthesis are applied to Schiff base derivatives and discussed below.  
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 functional group (imine) and are 
condensation products of the reaction of primary amines with aldehydes. Here, either 2-
methyl-2-pyridine-2-ylpropane-1,3-diamine (ppda) (in Chapters 2 and 3)  or 
diamino[2.2]paracyclophane (in Chapter 4) is used as the amine unit (see Figure 1.7), 
and either salicylic aldehyde or 2-pyridinecarboxaldehyde is used as the aldehyde for 
the Schiff base condensation reaction. While salicylic aldehyde is a standard aldehyde 
used in Schiff base chemistry, derivatives of 2-pyridinecarboxaldehyde are also 
explored. The latter is much more electron deficient and will allow for electronic 
tuning.  
 
Figure 1.7. Structure of ppda and diamino[2.2]paracyclophane, respectively. 
 
Ppda was introduced for the first time by L. Gade in 1997 [49]. The research 
group of Dr. Houser has used this pyridyldiamine as a common backbone to derive 
imine, amine and amide ligands (see Figure 1.8) and initial complexation studies with 
iron and copper revealed interesting results [50, 51].  
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Figure 1.8. Amine, imine and amide ligands derived from ppda. Highlighted in red are 
hydrogen atoms which can be readily removed using weak bases. 
 
The ligand H2L (see Figure 1.8) has reduced strain due to the single C–N bonds 
but having a secondary amine present, the N–H group is available for H-bonding 
interactions. Hydrogen bonding between N–H and the phenolate O-atom causes 
asymmetry and strain in binuclear iron complexes, previously shown by R. Shakya et al. 
[50]. A simplified representation of the coordination mode of that diiron complex is 
depicted in Figure 1.9. The OH-bridged diiron complex (OH originated from water) is 
structurally supported by intramolecular hydrogen bonding. This results in an off-linear 
bridging mode of the Fe–O–Fe unit and also causes a distinct, asymmetric coordination 
around each iron center. It was shown that introduction of tBu-groups into the phenol 
units changed the electronic effects of the diiron complex and the bulkiness of the tBu-
substituent caused the formation of an almost linear oxo-bridged complex without any 
inter-ligand hydrogen bonding.  
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Figure 1.9. Asymmetric coordination around the iron centers caused by NH–O 
hydrogen bonding. Each iron center is coordinated through L (N3O2 donor) in a 
pentadentate fashion, where N
py
 represents the pyridyl-nitrogen atom, NH is the amine 
and O is from phenolate (note: the bridging OH ligand originates from water). 
 
In a different study, using the three ligands depicted in Figure 1.8, we showed 
that nuclearity of copper complexes changes depending on the use of the amine, imine 
or amide functional group [51]. We obtained mono-, tri- and hexanuclear complexes. 
The pyridyl nitrogen atom does not coordinate in complexes with H2L and H2L
1
 (see 
representation of the copper(II) ion coordination environment in Figure 1.10) while 
when using H4L
amide
 pyridine does act as a donor (see Figure 1.11). The electrochemical 
behavior of the three complexes was studied and only the mononuclear complex [CuL] 
showed electrochemical reversibility.  
 
Figure 1.10. Represenation of the coordination environment around the copper 





Figure 1.11. Representation of the X-ray crystal structure of 
[Cu6(HL
amide
)4(H2O)2]. Each ligand is illustrated in a different color for clarity (green: 
copper, red: oxygen). Figure is adapted from reference [51]. 
 






) which are used in this work. The Schiff base 
formed from pseudo-ortho-4,12-diamino[2.2]paracyclophane produces a chiral complex 
when coordinated to the metal ion. Previously, Morvant has shown that H2L
5-ortho
, in the 
presence of copper, catalyzes cyclopropanation of alkenes [52]. However, the copper(II) 









. Highlighted in red are 
hydrogen atoms which can be readily removed using weak bases. 
 
1.4 Project Goals 
One of the project goals was to continue work on asymmetric diferric complexes 
using the reduced Schiff base H2L and explore whether the asymmetry caused by 
hydrogen bonding of the ligand would allow for stabilization of a mixed-valence 
diiron(II/III) complex, commonly found as an intermediate in catalytic cycles of 
asymmetric diiron enzymes. Thus far, one symmetric model complex has been made. 
However, it was shown to be very unstable. Additionally, it should be investigated if an 
electron withdrawing substituent (like NO2) on the ligand would significantly lower the 
reduction potential of the diferric complex, and if it would allow for the isolation of a 
more stable mixed-valence complex. Progress on the diiron chemistry is summarized in 
Chapter 2.  
Different copper complexes with ligands depicted in Figure 1.8 were formed to 
probe the electronic nature of the Cu(I)/Cu(II) redox couple. The use of the Schiff base 
H2L
1
 resulted in reversible electrochemical behavior. Following up on the electronic 
studies, it should be explored how much the redox potential of the copper ion could be 
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tuned by using different aldehydes. 2-Pyridinecarboxaldehyde seemed an appropriate 
candidate due to its electron poor nature and, hypothetically, it should allow for easier 
reduction of the complex. Using ppda as the amine and two equivalents of 2-
pyridinecarboxaldehyde yielded the symmetric ligand without any complications. One 
of the research goals was to synthesize the asymmetric ligand using one equivalent of 
each carbonyl with ppda to allow for accessibility of an intermediate redox potential. In 
order to obtain the pure asymmetric ligand, the ring structured hexahydropyrimidine 
intermediate was discovered to be important in aiding the synthesis of the asymmetric 
ligand. This chemistry is discussed in Chapter 3. Substantial parts of this chapter have 
been published in a journal article: Jozwiuk, A; Wang, Z.; Powell, D. R; Houser, R. P., 
Copper(II) complexes of symmetric and asymmetric bis(imine) ligands: Tuning the 
Cu(I)/Cu(II) redox couple. Inorganica Chimica Acta 2013, 394, 415-422. 
We know that the pyridyl group of H2L
1
 is non-coordinating and complexes that 
are formed with copper(II) ions are square planar. Instead of using ppda, 
diamino[2.2]paracyclophane would allow for significant addition of strain and force the 
metal center into a tense coordination environment. The question arose of how that 
would affect the geometry and electronic properties of the copper complex. The goal 
was to structurally and electrochemically characterize the pseudo-ortho and pseudo-gem 




 could be used as a catalyst in allylic oxidation reactions were performed 
and the question answered how the two conformers differ in reactivity. Attempts were 
also made on the synthesis of other metal complexes with the two ligands. The results 
are presented in Chapter 4. 
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2.1.1 Proteins with Diiron Cores  
The (hydr)oxo bridged diiron unit (see Figure 2.1) is commonly found in active 
sites of proteins [1-3]. This is not surprising due to the high stability and readily 
formation of this sub-structure in solution. The synthetic “spontaneous self-assembly” 
of a (μ-oxo)bis(carboxylato)diiron(III) core with different capping ligands L and 
carboxylates indicates a high thermodynamic stability of the diiron unit [1]. Typically, 
an iron(III) salt can be combined with NaO2CR and a ligand L in solution to yield 
[Fe2O(CO2R)2L] [4, 5].  
 
Figure 2.1. Schematic depiction of the μ-((hydr)oxo)diiron unit commonly found in 





 In (hydr)oxo-bridged diiron enzymatic active sites, carboxylate groups from the 
amino acids aspartate and glutamate are found to further support the core. Diiron 
proteins are nicely summarized in a review by Lippard [3] and some proteins will be 
discussed in the following to give the reader a broad introduction to the structural 
variety and the function of the individual sites. 
Hemerythrin (Hr), a protein found in marine invertebrates, is capable of 
reversibly binding dioxygen [6]. The active site contains a diiron unit that is hydroxo-
bridged and asymmetric. One iron ion is sixfold coordinated while the other iron has 
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five ligands. Two bridging acetate groups from aspartate and glutamate support the 
diiron unit by bridging the two iron centers (see Figure 2.2). The remaining ligands are 
five imidazoles from histidine residues. In the fully reduced state (deoxyHr) the diiron 
unit is hydroxo bridged and one iron site has only five donors, leaving one open 
coordination spot, where O2 can bind. After redox interaction with the metal centers, 
dioxygen is reduced to the hydroperoxo ion, the iron centers are oxidized to the diferric 
state and an oxo bridge remains (oxyHr). The hydroperoxo species is stabilized via 
hydrogen bonding to the bridging oxygen [7-9].  
 
Figure 2.2. Reversible O2 binding at the diiron site of hemerythrin. Figure is adapted 
from reference [7]. 
 
Another class of enzymes, namely soluble methane monooxygenase (sMMO), 
activates molecular oxygen and is capable of transferring one of the oxygen atoms onto 
a substrate (monooxygenase activity). This enzyme is found in methanotrophic bacteria 
(see Figure 2.3 for an illustration of the active site) and catalyzes the oxidation of 
methane to methanol [7]. This reaction is particularly of interest because the enzyme is 
capable of activating the C–H bond without over oxidation, a task difficult to mimic in 
synthetic chemistry. Currently the synthesis of methanol on industrial scale is 
performed via high pressure and high temperature syngas synthesis indirectly from 
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methane. First methane is converted with water to generate syngas (H2 and CO) which 
is then further reacted to give methanol in another step [10]. 
 
Figure 2.3. Active site (hydroxylase component) of sMMO in its reduced and oxidized 
(resting, MMOH) state, respectively. Figure is adapted from reference [7]. 
 
In the resting state of the active site (MMOHox) two iron(III) ions are bridged 
through two hydroxo ligands and one glutamate [11]. MMOHox can be reduced to create 
the diferrous intermediate MMOHred, which is capable of activating dioxygen. The 
reduced form shows one five- and one six-coordinated iron center. One glutamate is 
bridging in 1,3-fashion while the other glutamate shows a 1,1-fashion and is chelating 
one iron site. Upon O–O bond scission, eventually a high-valent diiron(IV) diamond 
core, Fe2(μ-O)2 (intermediate Q), forms [12]. The latter is capable of breaking the 
alkane C–H bond of substrates and a proposed mechanistic pathway can be found 
elsewhere [13]. It is of great interest to understand the enzymatic reaction process of 
this enzyme to build simpler, synthetic, models that could act as a catalyst under 
ambient conditions.  
Class I ribonucleotide reductase (RNR) represents a class of proteins where the 
diiron unit (found in the R2 domain of the protein) is interacting with dioxygen but the 
iron centers themselves are not involved in catalysis. Instead, a tyrosine residue, which 
31 
is in close proximity to the metal site, is transformed into a radical by the diiron center 
[7, 14]. The radical itself is then involved in the conversion of ribonucleotides to 
deoxyribonucleotides. This enzyme is found in a variety of species, from E. coli to 
humans. Since it is important for DNA biosynthesis, further studies on RNR could 
reveal important new attacking points for novel anticancer treatments/drugs. 
 
Figure 2.4. Representation of the active site in ribonucleotide reductase. Figure is 
adapted from reference [7]. 
 
The above depicted (Figure 2.4) active site R2 in RNR is shuttling in oxidation 
states between the diferric and diferrous form. In the reduced form, the iron centers are 
bridged via two glutamates and overall five-coordinated. The diferric site shows an oxo-
bridge between the iron ions and the metals are only bridged through one glutamate 
[14]. The second glutamate has shifted and only coordinates to one iron center in a 
terminal mode. Additionally, one water molecule is found at each iron site resulting in 
overall sixfold coordination. Exposure to O2 causes the transformation from the reduced 
to the oxidized species and the formation of the tyrosine radical. Proposed mechanisms 
for this transformation can be found in the literature [15].   
 The active sites of Hr, MMOH and R2 in RNR have a diiron core in common, in 
which both iron centers are redox-active. In addition, the iron ions are held in position 
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by glutamate, histidine and aspartate (no aspartate in MMOH). In their reduced states 
all have at least one iron center which is ligated by only five donors. This allows for 
interaction with dioxygen through the open coordination spot and all diiron centers, in 
fact, are sensitive to O2. R2 and MMOH are structurally similar in the sense that one μ-
1,3-glutamate remains coordinated to both iron centers during catalytic turnover. The 
other glutamate, even though coordinating in 1,1-fashion in MMOHred and 1,3-fashion 
in R2red, similarly shifts to one iron center upon oxidation which results in terminal 
coordination. On the other hand, the discussed diiron centers are different because of 
unique coordination environments and differences in bridging modes and the kind of 
ligands used for bridging. Hr is structurally very different from MMOH and R2. This 
probably explains the difference in interaction with molecular oxygen; allowing Hr to 
reversibly bind O2.  
While mixed-valence states of the diiron sites in hemerythrin [16], 
ribonucleotide reductase [17] and methane monooxygenase [18] have been artificially 
induced and subsequently characterized, there is no evidence for the presence of a 
naturally occurring mixed-valence state in these proteins. However, there are other 
diiron sites, found in proteins, which transition through the mixed-valence states in the 
catalytic cycle of reactions. Here, two proteins, namely rubrerythrin and purple acid 
phosphatase, will be introduced with the focus on their mixed-valence intermediate. 
Rubrerythrin (Rbr) is found in thermophilic bacteria and plays a role as an 
oxidative stress inhibitor as it catalyzes the reduction of hydrogen peroxide to two 
equivalents of water [19]. It was found that Rbr, in stark contrast to the previously 
discussed diiron sites, only reacts slowly with dioxygen, implying it has no O2 
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activation function [20]. The active site in Rbr has the most “plastic” iron centers, 
meaning the most change in movement of one of the iron centers during the catalytic 
cycle is observed compared to other diiron containing enzymes, and a schematic 
description of the iron movement upon change in valence is shown in Figure 2.5 [19]. 
This figure also represents the coordination environment around the iron centers. X-ray 
crystallographic data has only been obtained for the all-ferric and all-ferrous state of the 
enzyme [21]. Both oxidation states have in common that two glutamate residues are 
bridging the iron centers. Additionally, the fully oxidized site has an oxo-bridge which 
connects the two iron centers. While there is not much of a structural change in the iron 
center depicted on the right site, the iron shown on the left site undergoes glutamate to 
histidine ligation switch upon reduction. In the ferric state E97 functions as a terminal 
donor and H56 does not interact with the iron ion. After reduction to iron(II) the metal 
center moves almost 2Å towards the histidine allowing coordination to H56, and E97 




Figure 2.5. Schematic representation of the movement of the iron ion in rubrerythrin 
upon change in oxidation state. Figure is adapted from reference [22]. 
 
 A proposed catalytic cycle for the reduction of hydrogen peroxide is shown 
below in Figure 2.6. The all-ferrous site is sixfold-coordinated. However, there is one 
labile water ligand at each iron center. Upon coordination of H2O2, these two water 
ligands are displaced. A redox reaction occurs and the active site is oxidized to an oxo-
bridged species. One of the dihydroperoxo oxygen atoms was incorporated into the 
bridge while the other one is lost as a water molecule. The diiron unit is then reduced 
and protonated yielding in a mixed-valence hydroxo-bridged species. The addition of 
another proton and electron finally results in the regeneration of the initial diferrous 
state. The bridging O(H) is eventually lost as another molecule of water during 
turnover. It should be highlighted that a glutamate residue (E97), which sits right above 
the diiron center, is interacting with the diiron unit by allowing hydrogen bond 
formation with certain intermediates (see Figure 2.6). This interaction of a carboxylate 
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residue is exceptional for diiron active sites. Studies on mutants, which lack E97, 
revealed that a mixed-valence state of the enzyme cannot be observed as an 
intermediate, implying that E97 has an important function in the catalytic cycle und the 
formation of the mixed-valence state [23]. 
 
Figure 2.6. Proposed catalytic cycle of hydrogen peroxide reduction at the diiron site in 
rubrerythrin. (Two iron bridging glutamates have been removed for clarity). Figure is 
adapted from reference [19]. 
 
Purple acid phosphatase (PAP) is a diiron containing enzyme, which catalyzes 
the hydrolysis of phosphoric acid monoesters and anhydrides, such as ADP and ATP 
[24]. Mechanistic pathways of this hydrolysis are proposed [25, 26]; it appears that the 
metal ions of the active site act as Lewis acids, being coordinated by a phosphoester to 
facilitate a nucleophilic attack by hydroxide onto the phosphorus atom. This protein was 
isolated mostly in spleens, bones and lungs of humans, and high levels of PAP have 
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been associated with some diseases like hairy cell leukemia [27] and AIDS [28]. While 
the active form of PAP in mammals is in the mixed-valence diiron state (Fe(III)/Fe(II)), 
plants exhibit a Fe(III)/Zn(II) active site (see Figure 2.7) [24]. The mammalian protein 
is not active in the diferric sate and it has been speculated that the oxidation/reduction 
allows for in vivo regulation to turn the activity off/on, respectively [29]. In the 
following we will focus on the diiron containing active site of mammals. One hydroxo 
ligand, as well as one oxygen atom from a carboxylate group (aspartate), is bridging the 
two iron centers. This active site is particularly interesting because of the great 
asymmetry in coordination around each iron site (see Figure 2.7). The “chromophoric” 
site (left in Figure 2.7) causes the purple color of the enzyme due to a charge transfer 
transition from tyrosinate to iron(III). The absorption is located at around 550 nm with 




. The Solomon group has nicely described the 





Figure 2.7. Active site of purple acid phosphatase with Me(II) = Fe(II) or Zn(II) in 
mammals or plants, respectively. Figure is adapted from reference [24]. 
 
The other metal site (right in Figure 2.7) is referred to as the “redox active site”. 
This term appears a bit misleading as the ferric state inactivates the function. It is 
suspected, that PAP plays several other roles in vivo, such as the transport of iron [31], 
bone resorption [32] and immune response [33]. It is also believed that the enzyme 
catalyzes reactions via Fenton-like chemistry [34-36]. 
Rbr and PAP are both non O2-activating enzymes and have in common that a 
mixed-valence species is involved in catalysis. While in PAP, the Fe(II)/Fe(III) state is 
essential to start a turnover, in Rbr the mixed-valence state is part of the turnover cycle. 
The main difference between the two enzymes is that the metal centers in PAP act most 
likely as Lewis acids in the case of phosphoester hydrolysis. There is only some 
evidence that the iron centers could undergo Fenton-like chemistry in which case the 
iron centers act as redox-active sites. In Rbr the iron ions undergo redox changes from 
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the all-ferric to the all-ferrous state and a mixed-valence state is detected during the 
catalytic cycle. 
 In summary, there are a variety of diiron active sites known thus far. It was 
shown that even though all proteins have a diiron unit with similar bridging ligands 
((hydr)oxo and carboxylate residues) in common, each protein has a different function 
in biology. Model compounds, which mimic these active sites in proteins have been 
introduced to the literature during the last couple of decades and in the following 
section an overview of these synthetic complexes with a focus on mixed-valence diiron 
model complexes will be given. 
 
2.1.2 Model Complexes for Diiron Sites  
A good number of unsupported, only O-bridged diiron complexes have been 
synthesized in mostly the ferric state [1]. Unsupported OH-bridged complexes on the 
other hand, are very rare. Particularly for the Fe(II)/Fe(II) state there is only one 
example, which was reported by Grohmann et al. The diferrous complex was 
synthesized with a pentadentate pyridyl-tetra(amine) ligand and the structure of the 
complex is shown in Figure 2.8 [37]. Mixed-valence forms of mono-bridged (oxo or 
hydroxo bridged) diiron complexes have not been isolated thus far. Unsupported, singly 
O(H)-bridged complexes do not seem to be very relevant for diiron active site structural 
model studies because of the difference in the bridging angle. In proteins the structures 
are bent (between around 120° to 130°) due to additional bridging carboxylates  and 
there is only a small change in bending when the bridge is de/protonated [2].  
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Figure 2.8. Crystal structure of the only OH-bridged, unsupported, diferrous complex. 
Figure is adapted from reference [37]. 
 
(μ-Oxo)bis(μ-carboxylato)diiron(III) complexes are structurally the closest 
model compounds for diiron enzyme active sites. They assemble when tridentate N-
donor ligands are dissolved in the presence of iron salts and carboxylates. The tridentate 
ligands hydrotripyrazol (HBpz3), tris(pyridyl)amine (TPA) or 1,4,7-trimethyl-
triazacyclononane (Me3TACN) have been used widely and the ligand structures are 
shown in Figure 2.9 [2]. 
 
Figure 2.9. Structures of HBpz3, TPA and Me3TACN. 
 
Common for all tri-bridged diiron structures is symmetry within the complex 
which gives the molecule two equivalent iron sites. Figure 2.11 a) and b) shows crystal 
structures with the (μ-oxo)bis(μ-carboxylato)diiron(III) core which are representative 
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for this class of structural mimics [4, 5, 38-40]. While the iron–ligand bonds found in 
these synthetic complexes match well with the ones found in differic enzymes, the 
Fe···Fe distances are shorter and the Fe–O–Fe angles are significantly smaller. Some of 
these complexes have been partially characterized in their mixed-valence form, which 
will be discussed at the end of the background section. 
 
Figure 2.10. Structure of 5-Me-HXTA. 
 
 Another class of model complexes has been studied where phenolate or other 
alkoxo-groups are bridging. A structure of a representative complex of this class, 
(Me4N)[Fe2(5-Me-HXTA(OAc)2], using the 5-Me-HXTA ligand (see Figure 2.10) is 
shown in Figure 2.11 d) [41]. Structurally these complexes are unrelated to natural 
diiron sites but they can be isolated in their mixed-valence states and appear stable [42-
45]. In the solid state, the valences are localized giving distinct differences in iron–




Figure 2.11. Crystal structures of selected diiron-containing enzyme model complexes. 
(a) [Fe2O(OAc)2(HBpz3)2], (b) [Fe2O(O2P(OPh))2(Me3TACN)2], (c) 
[Fe2O(OBz)(TPA)2](ClO4)3, (d) (Me4N)[Fe2(5-Me-HXTA(OAc)2]. Figure is adapted 
from reference [2]. 
 
 An unexpected complex was derived with the use of TPA as a ligand. Figure 
2.11 c) shows the structure of [Fe2O(OBz)(TPA)2](ClO4)3. This is the only example of a 
ligand coordinating each iron site in different fashion. It results in asymmetric bond 
lengths on either iron site. The authors speculated that unfavorable H–H interactions 
would arise in the symmetric version of the complex [47], [48]. 
 Before the mixed-valence model complexes will be discussed, the reader should 
gain more understanding in the classification of mixed-valence compounds. Therefore, 
the next section will focus on examples for the different kinds of mixed-valence 
classifications according to Robin and Day. 
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 Prussian blue [49-51], not only the first synthetic coordination compound, was 
probably also the first mixed-valence compound and up to now many more have been 
synthesized, with the use of different metal ions [52-54]. Not all mixed-valence 
complexes are alike. Today’s most valid classification of mixed-valence complexes is 
based on the work of Robin and Day [55], who categorized mixed-valence complexes 
based on the strength and symmetry of the ligand fields about each metal center. The 
classes I-III are used to describe the mixed-valence situation.  
Complexes within the class I exhibit different symmetry and ligand field 
strength at each metal center. The interaction between the two metal centers due to the 
different environment or great distance to each other results in properties which are 
typical for isolated metal centers. For example, a complex where M(III) is in the low 
spin configuration and M(II) is high spin. Therefore, spectra of theses complexes appear 
as a sum of the fully oxidized and fully reduced complex. Those complexes appear 
mostly colorless, do not show coupling between the metal ions and are insulators.  
In contrast, if the M(II) and M(III) ions are in equal environments, the complex 
falls into class III and the electrons are considered delocalized. Both metals couple 
strongly and the material shows conductivity. Overall, properties of these complexes are 
completely different from the isolated fully oxidized/reduced species. The coupling 
depends strongly on the distance of the metal ions to each other. The shorter the inter-
metal distance, the stronger the coupling. 
The class II represents complexes where the two coordination sites are 
distinguishable but delocalization of electrons occurs. A typical example for a mixed-
valence class II complex is a compound which has the reduced and oxidized ion in 
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octahedral sites but exhibits different metal-ligand bond distances. It is common that 
bridged metal complexes fall into the class II. 
Class II complexes feature absorptions in the visible region from 14000–27000 
cm
–1
 (~714–370 nm) which are not present in spectra of the fully oxidized or reduced 
species. The transition (intervalence electron transfer) is assigned to M(II) + M(III) to 
M(III) + M(II). There is magnetic coupling between the two metal centers which can be 
detected via magnetic susceptibility measurements. Overall complexes within this class 
show low conductivity. 
Two synthetic O(H)-bridged diiron complexes have been isolated thus far which 
fall into class II. Both of them have symmetric sites and are described below. 
The OH-bridged mixed-valence complex synthesized by Wieghardt and 





L](ClO4)2, a blue-violet complex (with L = 
Me3TACN), can be isolated in crystalline form at low temperature, whereas in solution, 
even if kept free of dioxygen, this complex readily decomposes. The crystal structure of 
the mixed-valence complex is depicted in Figure 2.12. 
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L](ClO4)2. Figure is adapted from 






L](ClO4)2 exhibits an Fe···Fe distance of 3.400(3) Å 
and a bond angle of 118.1(2)° for the Fe–O–Fe bridge. Interestingly the Fe–O distances 
are not equal (Fe(1)–O(1) = 2.005(5) Å whereas Fe(2)–O(1) = 1.961(5) Å). This 
difference in bond length is interpreted as a localized, class II, mixed-valence complex 
according to Robin and Day. Therefore, Fe(2) can be formally assigned to the Fe(III) 
oxidation state and Fe(1) to the Fe(II) oxidation state. The magnetic coupling accounts 
for J = –12.9 cm
–1
 with a ground state of S = ½. EPR spectra taken at 10 K confirm the 
S = ½ ground state. According to Mössbauer spectroscopy the valence of this complex 
appears to be localized with both iron ions being in the high spin state.  
When the mixed-valence complex is dissolved in aceto- or butyronitrile at room 
temperature it decomposes within half an hour, which is indicated by a color change to 








 but quantitative analyses revealed that only half of the mixed-valence 












 doubles upon exposure to air. Wieghardt et al. propose a mechanism 






 which is depicted in Scheme 
2.1. 
 
Scheme 2.1. Possible protonated and redox species of the diiron centers. Scheme is 
redrawn from reference [56]. 
 
The starting mixed-valence complex D, as shown in Scheme 2.1, is in 
equilibrium with its de/protonated forms E and C. The more protonated species is a 
stronger oxidizer (e. g. C is a stronger oxidizer than D) and will cause intermolecular 
electron transfer from D to C when both species are present. This results in the 
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formation of A and F, respectively. By analogy, D and E will result in the formation of 
B and G. Since F is a fairly strong acid, G is readily formed and autocatalysis is 
enhanced through protonation of D. 
Using the same ligand (Me3TACN), a mixed-valence diiron oxo-bridged 
complex was formed in situ upon controlled-potential coulometry of 
[Fe2O(OAc)2(Me3TACN)2](PF6)2 [5]. Instead of pivalic acid, two acetate molecules act 
as bridging ligands. The mixed-valence species is described as a green complex, and 
initial EPR and Mössbauer data were collected. The mixed-valence complex exhibits a 
high spin iron(II) and a high spin iron (III) ion with a ground state of S = ½.  
About 10 years later, the group of Sanders-Loehr [57] successfully isolated the 






 (L = 
Me3TACN), and determined its crystal structure. Bulkier triphenylacetates have been 
used in their study to support the diiron unit. Scheme 2.2 summarizes the different 
synthetic routes that have been tried in order to obtain the green mixed-valence complex 
from the fully reduced [Fe2OH(O2-CCPh3)2L2](BPh4). Starting from the hydroxo-
bridged diferrous complex, the mixed-valence state can be formed upon reaction with 
molecular dioxygen, hydrogen peroxide or 4-methylmorpholine N-oxide. EPR and 
magnetic data of the mixed-valence species indicate a spin state of S = ½, which is 
consistent with the mixed-valence assignment to the complex. Resonance Raman 
studies provide insight into the symmetry of the Fe–O stretch and revealed that the 
isolated complex in fact shows trapped-valence character. The crystal structure of 
[Fe2O(O2-CCPh3)2L2]BPh4 reveals an iron···iron distance for the mixed-valence state to 
be 3.155(1) Å and a bond angle of Fe–O–Fe = 123.4(2)°. The similar length of 1.818(4) 
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Å and 1.844 (4) Å for the Fe–oxo bond does not allow for distinction between a 
delocalized or trapped-valence classification. Further analysis of this complex is 
provided in a different publication by Payne et al. [58]. They isolated the same mixed-
valence complex with a different counter ion, [Fe2O(O2-CCPh3)2L2]OTf. The difference 
between the Fe–O bonds is more significant with 1.800(4) and 1.847(4) Å indicating 
class II character with distinguishable iron ions. 
 
Scheme 2.2. Conversion of the OH-bridged differic complex to the mixed-valence oxo-
bridged species. (R = CPh3, R3NO = 4-methylmorpholine N-oxide). A second 
equivalent of each oxidant converts the mixed-valence species to the oxo-bridged 
diferric complex. Scheme is adapted from reference [57]. 
 
 Given the fact that there are only few mixed-valence intermediates for μ-
(hydr)oxodiiron complexes, it is obvious that they are difficult to access and study. All 
mixed-valence complexes characterized thus far utilize Me3TACN as a capping ligand 
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and two supporting RCO2
–
 bridges. It seems that oxo-bridged mixed-valence complexes 
are more stable than OH-bridged complexes. 
 
2.2 Introduction  
The group of Dr. Houser synthesized the first O(H) bridged, unsupported (singly 
bridged) but asymmetric diiron complexes [59]. Scheme 2.3, below, summarizes the 









Scheme 2.3. Representation of the synthesis of complexes done by R. Shakya. (i) 
Fe(ClO4)3·6H2O, Et3N, CH3OH. (ii) NaBPh4, CH3OH. (iii) FeCl3, Et3N, CH2Cl2. 
Protons highlighted in red represent readily deprotonable hydrogens. Scheme is redrawn 
from reference [59], small changes were made to the labeling. 
 
The reduced Schiff bases, H2L and H2L
tBu
, are generated from condensation of 
ppda with salicylic aldehyde or 3,5-Di-tertbutyl-2-hydroxybenzaldehyde, respectively 
and subsequent reduction. Monomeric or dimeric iron complexes are obtained 
depending on the nature of the anionic counter ion. While the use of chloride facilitates 
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the formation of the pentadentate monomeric complexes with a coordinating chloride in 
the sixth position, the use of non-coordinating ions like perchlorate allows the formation 
of dimers. The focus will be on the dimeric complexes which are structurally related to 
the diiron containing enzymatic active sites. The crystal structure of [(FeL)2(µ-
OH)]BPh4, shown below in Figure 2.13, reveals the asymmetric nature of the complex. 
 
Figure 2.13. Crystal structure of [(FeL)2(µ-OH)]BPh4. The counter ion and trapped 
solvent molecules are omitted for clarity. Figure is adapted from reference [59]. 
 
The internal hydrogen bonding, which is caused by our unique ligand manifold, 
results in a bent structure and a distinct coordination environment around each iron 
center. On the other hand, when the ligand was substituted with tBu-groups, an oxo-
bridged dimer without internal hydrogen bonding was obtained. The crystal structure is 
shown in Figure 2.14. 
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Figure 2.14. Crystal structure of [(FeL
tBu
)2(µ-O)]. Figure is adapted from reference 
[59]. 
 
The electrochemical behavior of the two dimers was studied through cyclic 
voltammetry, and both voltammograms are overlayed in Figure 2.15. [(FeL)2(µ-
OH)]BPh4 shows metal centered redox couples at –630 mV (ΔE = 120 mV) and –1190 
mV (ΔE = 165 mV) and one irreversible ligand oxidation at around + 830 mV vs. 
Ag/AgCl. [(FeL
tBu
)2(µ-O)] does not show any metal-centered redox features within the 
solvent window. This means that metal-based redox reactions are not accessible for this 
complex under the conditions picked. Instead two quasi-reversible and one irreversible 
ligand based oxidations are observed at 550 mV (ΔE = 130), 825 mV (ΔE = 156) and 
1086 mV (ΔE  = 270) vs. Ag/AgCl, respectively. 
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Figure 2.15. Cyclic voltammogram of [(FeL)2(µ-OH)]BPh4 (1) and [(FeL
tBu
)2(µ-O)] (2) 
vs. Ag/AgCl, sample concentrations about 1.0 mМ in CH2Cl2, scan rates 150 mV/s, 0.1 
M TBAH supporting electrolyte. Figure is adapted from reference [59]. 
  
The work by R. Shakya left several questions open to be answered. According to 
the CV of [(FeL)2(µ-OH)]BPh4 the comproportionation constant can be calculated and 









In equation 2.1 Kc represents the comproportionation constant (higher values 
indicate a more stable mixed-valence complex) and ΔE represents the difference 
between two redox couples (here diferric/mixed-valence and mixed-valence/diferrous) 
[60], [61]. Equation 2.2 represents the comproportionation equilibrium reaction. With a 
Kc of ≈ 10
11
 for [(FeL)2(µ-OH)]BPh4, a reasonably stable mixed-valence complex is 
expected, and the crystal structure of [(FeL)2(µ-OH)]BPh4 suggests the formation of a 
localized mixed-valence complex upon reduction due to the different coordination 
environment around each iron center. In this chapter, the stability of the mixed-valence 
form is studied. Does asymmetry in our complex result in stabilization of the mixed-
valence intermediate? The synthesis and characterization of a nitro-substituted ligand 
should answer the question of whether the electronic changes in the ligand would allow 
for easier reduction and maybe better stabilization of a potential mixed-valence 
complex. 
Further, it was speculated whether the deprotonated complex [(FeL)2(µ-O)]BPh4 





2.3 Syntheses  
Scheme 2.4 summarizes the syntheses and reaction pathways of [(FeL)2(µ-O)], 
[FeL(MeOH)], [(FeL)2], [(FeL
NO2
























































































































The ligand H2L is prepared by Schiff base condensation of ppda with two 
equivalents of salicylic aldehyde in methanol followed by reduction with sodium 
borohydride. For this work, the preparation of [(FeL)2(µ-OH)]BPh4 differed slightly 
from what was previously published [59]. Upon deprotonation of H2L in MeOH, a 
solution of ferric perchlorate was added. After counterion metathesis with NaBPh4, the 
complex precipitated out of solution. It was then dried, redissolved in dichloromethane, 
and recrystallized by vapor diffusion with pentane to obtain [(FeL)2(µ-OH)]BPh4 
·CH2Cl2, in contrast to the previous study where it was crystallized from methanol and 
[(FeL)2(µ-OH)]BPh4·MeOH was isolated. Conversion between [(FeL)2(µ-OH)]BPh4 
and [(FeL)2(µ-O)] was achieved via (de)protonation, and [(FeL)2(µ-O)] can also be 
obtained by reducing [(FeL)2(µ-OH)]BPh4 with cobaltocene in dichloromethane 
solution, followed by spontaneous disproportionation, deprotonation, and subsequent 
oxidation under atmospheric conditions, which will be discussed later. [(FeL)2(µ-O)] is 
also generated through oxidation of the ferrous complex [FeL(MeOH)], which was 
synthesized by treatment of H2L with NaH to deprotonate the phenol group, then 
reaction with ferrous chloride in methanol. When [FeL(MeOH)] is recrystallized from 
MeCN, the dimeric complex [(FeL)2]·(MeOH)2 was obtained. [(FeL
NO2
)2(µ-OH)]ClO4 
was produced upon reaction of H2L
NO2






2.4 Solid State Structures 
2.4.1 X-ray Crystal Structures 
Similar to the previously published complex [(FeL)2(µ-OH)]BPh4·MeOH, 
structures of [(FeL)2(µ-O)] and [(FeL
NO2
)2(µ-OH)]ClO4 show coordination to the ferric 






,  respectively, 
and exhibit the same kind of intramolecular hydrogen bonding between the two 
subunits. A (hydr)oxo ligand acts as the sixth donor and bridges two ferric ions. On the 
other hand, the diferrous complex [(FeL)2] is doubly bridged through one of the 
phenolate donors of each ligand, resulting in sixfold coordination of the metal center 
with absence of additional donors. All of our μ-OH complexes are able to hydrogen 
bond to a solvent molecule via one of the amine N–H’s and the bridging OH. In 
[(FeL)2(µ-OH)]BPh4 methanol is trapped, while in [(FeL
NO2
)2(µ-OH)]ClO4 water is 
present. Similarly, the N–H of [(FeL)2(µ-O)] hydrogen bonds to acetone. This 
phenomenon is discussed in detail later. 
The neutral complex [(FeL)2(µ-O)] (see Figure 2.16) shows distorted octahedral 
coordination around the Fe(III) centers, utilizing the N3O2 donors from (L)
2–
 and the O 
from an oxo ligand. The latter connects two iron centers via μ-fashioned coordination 
(Figure 2.16).  Again, as in [(FeL)2(µ-OH)]BPh4, the coordination environment of each 
iron site differs. While Fe1 has the oxo bridge O1 and the pyridine nitrogen N18A trans 
to each other, Fe2 shows the oxo bridge O1 and the amine nitrogen N20B coordinating 
opposite to another.  
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Figure 2.16. Representation of the X-ray structure of [(FeL)2(µ-O)] with H-atoms 
removed for clarity (except H-atoms which are involved in intramolecular hydrogen 
bonding). 
 
The different coordination environments around each iron center results in 
slightly different Fe–donor bond lengths on the two different sites, as can be seen in 







Fe–O refers to the iron ion having the pyridine-N atom trans to the µ-
O(H) and 
cis-Py








Table 2.1. Comparison of Fe–O–Fe core unit parameters. Parameters for [(FeL)2(µ-
OH)]BPh4·MeOH  and [(FeL
tBu
)2(µ-O)] are taken from reference [59]. 




Fe–O (Å) Fe···Fe (Å) 
[(FeL)2(µ-OH)] 
BPh4·MeOH 
138.64(9) 2.0174(16) 2.0033(17) 3.7616(7) 
[(FeL)2(µ-OH)] 
BPh4·CH2Cl2 





140.05(9) 2.0028(16) 1.9689(16) 3.733(5) 





 169.4(6) 1.844(10) 1.793(10) 3.621(4) 




)2(µ-O)] both pyridine ligands are trans to the oxo-bridge. 
 
In stark contrast to [(FeL)2(µ-OH)]BPh4, the Fe–O1 bond lengths for each 
subunit are very similar with 1.8192(17) Å for Fe1–O1 and 1.8160(17) Å for Fe2–O1 
(see Table 2.2 for selected bond lengths and angles). It is likely that the stronger 
antiferromagnetic coupling through an oxo vs. a hydroxo bridge [62] compensates for 
the asymmetric charge distribution of the individual units. Overall, the Fe–O1 bonds in 
[(FeL)2(µ-O)] are shorter than in [(FeL)2(µ-OH)]BPh4, which can be explained with the 
higher electrostatic interaction between iron(III) and an oxo donor compared to iron(III) 
and hydroxo. The hydrogen bonding between the amine NH group from N9A/N20A 
and phenolate O O1B/O28B most likely causes the bent structure with an Fe1–O1–Fe2 
bond angle of 143.70(10)°. Due to this unique intramolecular hydrogen bonding, the 
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bridging angle in [(FeL)2(µ-O)] is only 5° more obtuse than in our OH-bridged complex 
[(FeL)2(µ-OH)]BPh4. Most unsupported oxo-bridged diferric complexes have Fe-O-Fe 
angles of 160° to 180° [1] with a few exceptions, showing bridging angles of 140° [63] 
and 143° [64]. Our previously synthesized O-bridged complex with the same ligand 
backbone (but tBu-substituted) does not show hydrogen bonding between the two 
subunits and the bridging angle is almost linear with 169.4(6)° [59]. Only the heme-like 
unsupported structure (μ-oxo)bis(tetraphenylporphyrinato)iron(III), which is sterically 
hindered, is another example where the bridging angle does not change significantly 
compared to its hydroxo-bridged analogue (differences of 3° and 7°, depending on the 
counter-anion of the complex) [65]. While unsupported oxo-bridged diferric complexes 
are rather linear, it is common for complexes with additional carboxylato bridges to 
range in Fe–O–Fe angles from 118°-138°, depending on the kind and number of 
bridging ligands [1].  
The X-ray structure of [(FeL
NO2
)2(µ-OH)]ClO4 also reveals a dimeric structure 
with two distinct coordination environments around each iron center, which is caused 
by a different orientation of the ligands due to hydrogen bonding interactions between 
the two subunits mentioned earlier. The structure of [(FeL
NO2
)2(µ-OH)]ClO4 (see Figure 
2.17) is very similar to [(FeL)2(µ-OH)]BPh4 but the counter ion in [(FeL
NO2
)2(µ-
OH)]ClO4 is perchlorate.  
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Figure 2.17. Representation of the X-ray structure of the cationic portion of 
[(FeL
NO2
)2(µ-OH)]ClO4 with H-atoms removed for clarity (except H-atoms which are 
involved in intramolecular hydrogen bonding and bridging OH). 
 
As in [(FeL)2(µ-OH)]BPh4, the bond lengths of the hydroxo O-atom to Fe(III) 
are different for each site with Fe1–O1 being 1.9689(16) Å and Fe2–O1 being 
2.0028(16) Å (see Table 2.3 for selected bond lengths and angles). Both bonds are 
significantly shorter than in [(FeL)2(µ-OH)]BPh4. This is probably due to the electron 
withdrawing properties of the nitro-substituted ligand, which cause a slightly higher 
positive charge on the iron(III) ion and therefore stronger interactions with the bridging 
hydoxo ligand. Similar to [(FeL)2(µ-OH)]BPh4, the different coordination environment 
around each iron center in [(FeL
NO2
)2(µ-OH)]ClO4 show different bond lengths for the 
Fe–donor bonds as can be seen in Table 2. [(FeL
NO2
)2(µ-OH)]ClO4 has a Fe–O–Fe bond 
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angle of 140.05(9)° which is similar to the one in [(FeL)2(µ-OH)]BPh4 (138.64(9)°). 
 
Figure 2.18. Representation of the X-ray structure of [(FeL)2] with H-atoms removed 
for clarity (except NH-atoms from the amines). 
 
The complexes [(FeL)2(µ-OH)]BPh4, [(FeL)2(µ-O)] and [(FeL
NO2
)2(µ-OH)]ClO4 
are very similar with respect to asymmetric coordination fashion. The bridging angle 
ranges from 139 to 144° and there is only a small difference between the oxo and 
hydroxo bridged complex with L as the ligand which is most likely due to the fact that 
the diiron unit is held together in a bent fashion by two hydrogen bonds. The 
trans-Py
Fe–O 
bond is longer than the 
cis-Py
Fe–O bond in all complexes. The hydroxo-bridged 
complexes have longer Fe···Fe distances (around 3.7 Å) and longer Fe–O bonds than 
the oxo-bridged complex [(FeL)2(µ-O)] (Fe···Fe = 3.5 Å). All Fe–O–Fe core 
parameters are listed in Table 2.1 for comparison.  [(FeL
tBu
)2(µ-O)] has a different 
structure than the complexes mentioned before. It features symmetric coordination with 
both pyridine groups being trans to the bridging oxo-group. Also, there are no hydrogen 
bonds between the two subunits and the bridging angle is much higher (169°). The tBu 
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substituent most likely causes too much steric hindrance and therefore does not allow 
for similar alignment of the ligands as seen in the other complexes.  
  
The crystal structure of [(FeL)2] will be discussed separately as it is a diferrous 
complex and shows a significantly different coordination mode. In [(FeL)2], (L)
2–
 is the 
only donor and allows for distorted octahedral coordination via the μ-bridging abilities 
of the ligand (see Figure 2.18). The N3O2 donor set accounts for pentadentate 
coordination and one phenolate O-atom of each ligand bridges to the adjacent iron ion 
resulting in overall six-coordinate iron centers (see Table 2.4 for selected bond lengths 
and angles). This kind of metal bridging ability of the phenolate ligand is very common 
[66-70]. [(FeL)2] is a neutral complex and contains an inversion center which allows to 
transform equivalent atoms via -x+1, -y+1, -z+1. Although it is common for phenolate 
to act as a bridging moiety between two metal centers, to the best of my knowledge, 
diferrous bis(μ-phenoxy) complexes with an additional N3 donor around each iron 
center have not been reported thus far. Yet, N2O2 reduced Schiff base iron(II) 
complexes have been synthesized where two phenolate anions act as a bridge between 


















Fe1-O28A 2.0003(17) Fe2-O1B 1.9967(17) 

















O1-Fe1-O28A 101.83(7) O1-Fe2-O1B 96.19(7) 



















































Table 2.3. Selected bond lengths (Å) and angles (deg) for [(FeL
NO2
)2(µ-OH)]ClO4. 
Fe1-O1A 1.9315(17) Fe2-O1B 1.9134(16) 





































































































































Symmetry transformations used to generate equivalent atoms: for [(FeL)2] 
#1 –x+1, –y+1, –z+1       
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2.4.2 Hydrogen Bonding Pocket 
Complexes [(FeL)2(µ-OH)]BPh4, [(FeL)2(µ-O)], and [(FeL
NO2
)2(µ-OH)]ClO4 
have the capability of H-bond formation to H-bond acceptor molecules (see Figure 2.19 
for illustration).  
 
Figure 2.19. Schematic depiction of the hydrogen bonding pocket (
amine
N bonded to the 
H-atom represents the amine from the ligand; X represents a solvent donor atom 
capable of H-bonding; H atom attached to the oxo-bridge is either part of the hydroxo-
bridge or H atom from the solvent donor atom X in the case of [(FeL)2(µ-O)]). 
 
[(FeL)2(µ-OH)]BPh4 was previously synthesized from methanol [59] and shows 
hydrogen bonding to methanol via the ligand N–H and the bridging O–H hydrogen 
bond donors (see Figure 2.20, top). The H-acceptor atom from the solvent molecule 
forms a six-membered ring with the complex unit. However, when [(FeL)2(µ-OH)]BPh4 
is recrystallized from CH2Cl2/pentane, the pocket is open (see Figure 2.20, bottom) and 
no guest molecule is observed in the solid state; CH2Cl2 occupies other lattice space 




Figure 2.20. Space filling model of [(FeL)2(µ-OH)]
+
. Top: from R. Shakya: crystallized 
from methanol; bottom: my work: crystallized from CH2Cl2. 
 
Similar to [(FeL)2(µ-OH)]BPh4, [(FeL
NO2
)2(µ-OH)]ClO4 shows one molecule of 








. Top: with water; bottom: 
water removed to show pocket. 
 
In contrast to [(FeL)2(µ-OH)]BPh4 and [(FeL
NO2
)2(µ-OH)]ClO4, [(FeL)2(µ-O)] 
only exhibits one H-bond donor which is the ligand N–H, and when [(FeL)2(µ-O)] is 
recrystallized from wet acetone/pentane, one molecule of acetone interacts with the 
described hydrogen bond (see Figure 2.22), and a molecule of water and a second 
acetone are present elsewhere in the lattice. 
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Figure 2.22. Space filling model of [(FeL)2(µ-O)]. Top: with acetone; bottom: acetone 
removed to show pocket. 
 
If one considers the space filling model (see Figure 2.22), clearly the O-bridge 
seems sterically inaccessible and this is probably the reason why the highly basic O-
bridge does not get protonated by the water present in solution. On the other hand, when 
crystals are crushed up and dried under high vacuum, elemental analysis matches best 
with a formula of  [(FeL)2(µ-O)]·H2O.  
The H-bonding pocket, when occupied by an H-bond acceptor, X, can be 
compared to the H-bonding configuration in the mixed-valence state of the active site of 
rubrerythrin (see Figure 2.23) [19, 72].  
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Figure 2.23. Hydrogen bonding in the mixed-valence state of rubrerythrin (left) and in 
the diferric model complexes presented in this work (right). 
 
It seems likely that this H-bonding with glutamate (E97) stabilizes the mixed-
valence state in the enzyme by preventing proton transfer. Studies of Rbr mutants 
revealed that E97, which seems to be unique to this enzyme, is essential for the 
formation of a mixed-valent intermediate [23]. Model studies conducted by Wieghardt 
and colleagues [56] show that proton transfer from the bridging (hydr)oxo ligand is a 
key step in disproportionation. This suggests that an appropriate H-bond acceptor, X, 
might be able to trap the bridging proton in our complexes, thereby preventing proton 
exchange and ultimately stabilizing a mixed-valence state. A series of studies needs to 
be conducted to find a suitable X; if X is too basic, it will simply deprotonate the 
hydroxo bridge, but if it is too acidic, it may introduce free protons into the system. 
  
2.5 Chemical Reduction of [(FeL)2(µ-OH)]BPh4 
In a previous publication the synthesis and characterization of [(FeL)2(µ-
OH)]BPh4 were presented [59]. From the CV of [(FeL)2(µ-OH)]BPh4 (see Figure 2.15) 
it is possible to estimate the stability of a potential mixed-valence complex (FeII, FeIII) 
using equation 1. With a Kc of ≈ 10
11
 for [(FeL)2(µ-OH)]BPh4, a reasonably stable 
mixed-valence complex is expected, and the crystal structure of [(FeL)2(µ-OH)]BPh4 
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suggests the formation of a localized mixed-valence complex upon reduction due to the 
different coordination environment around each iron center. Cobaltocene (CoCp2) is an 
appropriate reductant according to its high reduction potential of –1.33V vs. Fc (in 
CH2Cl2) [73], and the fact that its potential lies in between the two redox couples.  
The reaction of the purple complex [(FeL)2(µ-OH)]BPh4 with CoCp2 in CH2Cl2 
resulted in a color change to yellow-orange and the formation of a yellow precipitate 
which was filtered off and identified as [CoCp2]BPh4. After removal of the solvent, a 
crude orange precipitate was isolated and [(FeL)2(µ-O)] was obtained after 
recrystallization in the presence of air.  
To further investigate the formation of [(FeL)2(µ-O)] upon reduction of 
[(FeL)2(µ-OH)]BPh4, a titration study was conducted in MeCN. After addition of 
CoCp2 solution to [(FeL)2(µ-OH)]BPh4, the band at 496 nm in the UV-Vis spectrum 
disappears while a new band grows in at 412 nm. Three isosbestic points can be 
detected at about 313, 358 and 434 nm. The absorption at 412 nm has about half of the 
intensity as the band at 496 nm after the addition of one equivalent of reductant (Figure 
2.24). The side product [CoCp2]BPh4 only adds slightly to the band at 412nm. (see 
Figure 2.25, absorption spectrum of [CoCp2]BPh4). After exposure to O2 the new band 
increases in intensity by about twofold without a significant shift in λmax.  
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Figure 2.24. Titration of [(FeL)2(µ-OH)]BPh4 (7.3 x 10
-5
 Μ) with up to 1eq. CoCp2 in 




Figure 2.25. UV-Vis of [CoCp2]BPh4 (0.9 x 10
-3
 Μ) in MeCN. Molar absorptivity at 







It is likely that half an equivalent of [(FeL)2(µ-O)] is formed from one 
equivalent of [(FeL)2(µ-OH)]BPh4 after reduction, and after subsequent exposure to O2 
all material is converted to [(FeL)2(µ-O)]. A mechanism is proposed, which is depicted 
in Scheme 2.5 and two paths for decomposition upon reduction are likely, both yielding  
[(FeL)2(µ-O)] and [(FeL)2(µ-OH2)] (see blue box in Scheme 2.5). The typically pale 





















































































The question which arises is how the products in the blue box are generated or 
what the mechanistic pathway could be like. Two paths are suggested (see path A and B 
in the scheme, Fe(II) ions are shown in red). In path A, two equivalents of [(FeL)2(µ-
OH)]
+
 are reduced, which results in the formation of two equivalents of mixed-valence 
[(FeL)2(µ-OH)]. If two of these species are in close proximity, disproportionation may 
occur, yielding diferric [(FeL)2(µ-OH)]
+
 and diferrous [(FeL)2(µ-OH)]
–
. The pKa of the 
differic complex should be lower (its bridging-oxygen atom is less basic because more 
electron density is shared with the iron(III) centers) than that of the diferrous complex, 
which causes formation of [(FeL)2(µ-O)] and ([(FeL)2(µ-OH2)] (see blue box). The 
alternate path for decomposition is also shown (path B). It is possible that upon addition 
of substoichiometric amounts of reductant, some of the mixed-valence complex 
[(FeL)2(µ-OH)] is formed. When mixed-valence [(FeL)2(µ-OH)] and unreacted 
[(FeL)2(µ-OH)]
+
 are in close proximity, proton transfer should occur from the ferric to 
the mixed-valence complex due to a difference in pKa, resulting in products [(FeL)2(µ-
OH2)]
+
 and [(FeL)2(µ-O)]. With the addition of another electron, it is probably more 
likely to reduce the cationic species. This results, again, in formation of the same 
products shown in the blue box.  
The difference between the two paths is that path A follows a disproportionation 
reaction, while in path B, two separate reductions occur. Both paths may yield in the 
same products. Moreover it could be that both paths occur simultaneously and even 
more equilibria between different species are transpiring. If path B is very fast, and path 
A may not be thermodynamically as favorable, it could be possible to trap the mixed-
valence complex by fixation of the bridging OH proton. The proper hydrogen bonded 
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host molecule, X, may hold the proton in position. This could allow for isolation and 
characterization of the mixed-valence complex. 
The oxo-bridged dimer has about a 1.2-fold higher absorption than the hydroxo-
bridged complex; this explains the difference in intensities in the final spectrum after 
oxygenation. Even under argon at –78°C, no other intermediates were captured when 
[(FeL)2(µ-OH)]BPh4 was treated with cobaltocene. Further studies, which are discussed 
in the electrochemistry section below, support the described decomposition of 
[(FeL)2(µ-OH)]BPh4 upon electrochemical reduction. 
The reaction pathway upon reduction of [(FeL)2(µ-OH)]BPh4 stays in good 
agreement with the work done by Wieghardt and coworkers, who trapped an OH-
bridged mixed-valence species and followed its decomposition to the oxo-bridged 
complex after time [56]. Yet, it is surprising that the mixed-valence species of 
[(FeL)2(µ-OH)]BPh4 is so unstable compared to Wieghardt’s complex which is stable 
for about half an hour at room temperature. It is possible that the difference in pKa from 
our complex compared to Wieghardt’s complex causes faster proton exchange, which 
drives the decomposition faster than for his complex. 
 
2.6 Electrochemistry 
The redox behavior of [(FeL)2(µ-OH)]BPh4 was previously described in 
methylene chloride [59]. In the work presented in this dissertation, all complexes are 
explored through cyclic voltammetry in acetonitrile solutions and the CV of [(FeL)2(µ-
OH)]BPh4 was repeated in acetonitrile in order to allow for reasonable comparison. 
Similar to what was seen in methylene chloride, complex [(FeL)2(µ-OH)]BPh4 exhibits 
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two quasi-reversible metal centered reductions at E½ = –1052 mV (ΔE = 131 mV) and 
E½ = –1724 mV (ΔE  = 192 mV) versus ferrocene which were initially assigned to the 
Fe(III)Fe(III) /Fe(II)Fe(III) and Fe(II)Fe(III) /Fe(II)Fe(II) couples, respectively. At 
positive potentials an irreversible ligand centered oxidation is found at +356 mV 
(Figure 2.26). 
 
Figure 2.26. Cyclic voltammograms (scan rate = 100 mV s
–1
; 0.1 M TBAPF6 
supporting electrolyte) of 1.0 mM solutions of [(FeL)2(µ-OH)]BPh4 (black line) and 
[(FeL)2(µ-O)] (red line) in MeCN. 
 
In contrast, [(FeL)2(µ-O)] shows only one quasi-reversible reduction feature at 
E½= –1824 (ΔE = 246 mV) assigned to the Fe(III)Fe(III)/Fe(II)Fe(III) redox couple. 
The second reduction feature is not accessible due to the limitations of the solvent 
window. There is also one irreversible feature at +145 mV which corresponds to ligand 
oxidation (Figure 2.26). The potential shift of the differic to ferrous/ferric couple, 
compared to that of [(FeL)2(µ-OH)]BPh4, seems reasonable because the oxo ligand in 
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[(FeL)2(µ-O)] causes higher electron density at the metal centers and therefore inertia 
towards reduction.  
Initial CV studies on powdered material having sufficient purity (according to 
elemental analysis) of [(FeL
NO2
)2(µ-OH)]ClO4 show similar redox features to [(FeL)2μ-
OH]BPh4. The metal featured redox couples are shifted 475 mV more positive (see 
Figure 2.27). This shift is reasonable due to the electron-withdrawing nature of the 
nitro-substituted ligand, resulting in more positive iron centers and thus more favorable 
reduction. No oxidative processes were observed within the solvent window of MeCN. 
In order to explore the nature of the metal centered redox features in more depth, more 
crystalline material of the complex has to be obtained. This is problematic because the 
crystallization is low yielding and takes several months. 
 
Figure 2.27. Cyclic voltammograms (scan rate = 100 mV s
–1
; 0.1 M TBAPF6 
supporting electrolyte) of 1.0 mM solutions of [(FeL)2μ-OH]BPh4 (black line) and 
[(FeL
NO2
)2(µ-OH)]ClO4 (red line) in MeCN. 
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Further studies on the electrochemistry of [(FeL)2μ-OH]BPh4 using different 
scan rates revealed more complex behavior. The first redox couple, assigned to 
Fe(II)/Fe(III), is chemically irreversible and electrochemically quasi-reversible. The 
quasi reversible behavior is valid because of the following criteria [74]: (1) E½ does not 
change significantly with scan rates; (2) ΔEp > 60 mV and increases with the scan rate; 
(3) Ipa/Ipc < 1 (here Ipa/Ipc ~ 0.5). At faster scan rates the back oxidation seems more 





Figure 2.28. CV of the first reduction peak of [(FeL)2μ-OH]BPh4 at different scan rates. 
 
Scanning to more negative potentials indicates that the second redox feature 
cannot be assigned to the mixed-valence to Fe(II)/Fe(II) couple. When the scan rate is 
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increased additional peaks show up in the CV (see Figure 2.29). It can be suggested that 
the incoming reduction peak at –1100 mV is actually related to the Fe(III)/Fe(II) to 
Fe(II)/Fe(II) couple. At low scan rates this peak is not observed because of the quick 
disproportionation of the mixed-valence complex. The peak centered at –1200 mV is 
more likely to be the Fe(III)/Fe(III) to Fe(III)/Fe(II) couple of [(FeL)2μ-O], which is one 
of the direct products of disproportionation described here. The incoming oxidative 
peak at –400 mV could be assigned to an oxidation of the diferrous complex. It would 
be difficult to calculate a new comproportionation constant Kc, without knowing, which 
peaks exactly corresponds to the Fe(III)/Fe(II) to Fe(II)/Fe(II) couple. However, since 
the incoming peaks at faster scan rates lie at more positive potentials, one can say that 
the separation of the two metal centered redox couples is smaller than estimated before 
and hence Kc will be smaller. This would be in agreement with the high instability of 
the mixed-valence species. 
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Figure 2.29. CV of the reduction peaks of [(FeL)2μ-OH]BPh4 at different scan rates. 
 
2.7 Spectroscopic Properties of Complexes 
The spectroscopic features of [(FeL)2(µ-OH)]BPh4 and [(FeL)2(µ-O)] are 
described in the following section. The main difference between the two complexes is 
the dramatic color change from dark purple for the hydroxo-bridged complex to an 




Figure 2.30. Powdered complex of [(FeL)2(µ-O)] (left vial) and [(FeL)2(µ-
OH)]BPh4 (right vial). 
 
The UV-Visible spectra of [(FeL)2(µ-OH)]BPh4 and [(FeL)2(µ-O)] exhibit three 
distinct bands in the range of 200 to 1000 nm. The near-UV features (less than 300 nm) 
are assigned as π–π* transitions of the phenolate groups [75]. The high energy transition 
(335-430 nm) is assigned to the CT from the out of plane pπ orbital (HOMO) of the 
phenolate oxygen to the d-orbital of the iron center. The low energy band (475-550 nm) 
arises from the in-plane pπ orbital (POMO) of the phenolate to the d π* orbital of the 
iron(III) ion [76]. The position and intensity of the LMCT band is sensitive towards the 
coordination environment of the iron center [30]. In [(FeL)2(µ-OH)]BPh4, the purple 
color, and therefore the band at around 500 nm brings to mind the CT band of purple 
acid phosphatase’s active site which is located at 510-560 nm (see introduction of 
Chapter 2) [25]. This is not surprising due to similarities in ligands that cause the CT 
band (phenolate here vs. tyrosinate in PAP).  
In [(FeL)2(µ-O)] the two high energy bands are similar to [(FeL)2(µ-OH)]BPh4. 
The iron ion in [(FeL)2(µ-O)] is a weaker Lewis acid than in [(FeL)2(µ-OH)]BPh4 
because of the stronger electron donation from the oxo ligand versus the hydroxo 
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ligand, respectively. Thus the d-orbitals in [(FeL)2(µ-O)] are higher in energy and create 
a greater energy gap for the LMCT (phenolate to iron) resulting in a blue shift [77]. 
There is only a slight increase in absorption for [(FeL)2(µ-O)] compared to [(FeL)2(µ-
OH)]BPh4 which is reasonable considering that the overall coordination is similar. The 
decrease of the O–Fe bond length in [(FeL)2(µ-O)] compared to [(FeL)2(µ-OH)]BPh4 
most likely causes the higher probability for the LMCT due to greater overlap of the 
orbitals. The significant difference in the absorption maximum of the POMO band in 
[(FeL)2(µ-OH)]BPh4 compared to [(FeL)2(µ-O)] makes it convenient to monitor the 
interconversion of the two complexes by UV-Vis spectroscopy. 
The absorption spectrum of [(FeL
NO2
)2(µ-OH)]ClO4 is dominated by a broad 
band at 380 nm with significantly higher molar absorptivity than seen in [(FeL)2(µ-
OH)]BPh4. This band is mainly assigned to π–π* transition within the nitrophenolate 
unit [78]. Most likely this band covers the higher energy LMCT. The lower energy 
LMCT is shifted to higher energy and also falls into the broad high absorbing feature 
[79]. The fact that the band at 380 nm masks the absorption features which reflect the 
nature of the coordination environment around the metal center, does not allow for pKa 
determination via UV-Vis titrations.  
 
2.8 Characterization of [(FeL)2] and Its Lability Towards Dioxygen 
The reaction of H2L with the ferrous salts FeCl2 or Fe(OTf)2 in the presence of 
base in methanol yields the complex [FeL(MeOH)] according to elemental analysis. 
The crude powder is either a monomer with MeOH in the sixth coordination position or 
a dimer with two molecules of methanol hydrogen bonded to the complex (even after 
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drying under high vacuum and heat the solvent molecule could not be removed). Upon 
recrystallization the neutral dimer [(FeL)2] is formed which still shows hydrogen 
bonding to one molecule of methanol for each dimer (solvent is omitted in the crystal 
structure depiction, Figure 2.18, for clarity). 
A solution of complex [FeL(MeOH)] in DCM rapidly reacts with O2 to give [(FeL)2(µ-
O)]. This reaction was monitored via UV-Vis spectroscopy where a change in 
absorption from 471 nm to 420 nm with a strong increase in absorptivity occurs (see 
Figure 2.31). Similar reactions have been observed in the past and a mechanistic 
pathway is proposed (see Scheme 2.6) [3].  
 
Figure 2.31. UV-Vis spectrum of [(FeL)2] in MeCN (λmax at 471 nm, ε = 1000) (black) 




Scheme 2.6. Mechanistic oxidation of Fe(II) by O2. Scheme is adapted from reference 
[3]. 
 
In a different experiment, complex [FeL(MeOH)] was prepared in methanol and 





was the counter ion). The formation of the hydroxo-
bridged complex over the oxo-bridged is not surprising due to the high basicity of 
[(FeL)2(µ-O)]. Mass spectra of [FeL(MeOH)] only show m/z = 879.2606, which 
corresponds to the protonated oxygenated product, [(FeL)2(µ-OH)]
+
. The coordination 
of tetradentate salan ligands to the Fe(II)-ion and the ability of the phenolate-O to act as 
a bridging unit has been studied recently and similar O2 reactivity was shown [71].  
 
2.9 Conclusion 
 In summary, the synthesis and characterization of new model complexes for 
active sites of asymmetric (hydr)oxo bridged diiron containing enzymes are presented. 
The complexes show unique intermolecular hydrogen bonding, which supports the 
bridging (hydr)oxo group and holds the iron units together in a bent configuration. 
De/protonation does not affect the bridging angle significantly. Further, a hydrogen 
bonding pocket was discovered at the differic center which should cause high pKa 
values of the oxo-bridge. This pocket also mimics the configuration in the mixed-
valence state of rubrerythrin’s active site. Further studies, with the use of different H-
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bond acceptors, X, will reveal if the proton from the hydroxo-bridge, once held in 
position, will allow for stabilization of the mixed-valence state. These studies will help 
to reveal the role of H-bonding between Glu97 and the diiron core in rubrerythrin. 
Further, it was shown that [(FeL)2(µ-OH)]BPh4 decomposes upon one electron 
reduction and subsequent proton exchange produces [(FeL)2(µ-O)]. This behavior is 
consistent for both chemical and electrochemical reduction. A reasonable mechanism 
for the decomposition is presented. Preliminary studies of [(FeL
NO2
)2(µ-OH)]ClO4 
suggest that it is easier to reduce, and ongoing experiments will explore its potential to 
form a mixed-valence complex. It was also shown that [(FeL)2(µ-O)] can be made via 




Unless otherwise stated, all reagents were used as received from commercial 
sources. 2-methyl-2-(pyridine-2-yl)propane-1,3-diamine (ppda) was synthesized 




 were synthesized 
according to the published procedures [70], [81]. Solvents used were doubly purified 
using alumina columns in a MBraun solvent purification system (MB-SPS). Infrared 
spectra were measured from 4000 to 400 cm
–1
 as KBr pellets, suspensions in Nujol or 
solutions on a Bio-Rad FTS155 FTIR spectrometer. 
1 
H NMR spectra were measured 
using a Varian 300 MHz instrument using solvent as an internal standard. Mass spectra 
were measured on a Q-TOF quadrupole time-of-flight mass spectrometer (Micromass, 
Manchester, U.K.) equipped with a Z-spray electrospray ionization (ESI) source. 
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Elemental analyses were performed by Atlantic Microlab, Norcross, GA. Cyclic 
voltammetry experiments were performed using a BAS 50W potentiometer and a 
standard three-electrode cell with a glassy-carbon working electrode, a Pt-wire auxiliary 
electrode, and an Ag pseudo reference electrode under an inert atmosphere at room 
temperature.  
Caution! Perchlorate salts of metal complexes with organic ligands are potentially 
explosive. Although no difficulty was encountered during the syntheses described 
herein, complexes should be prepared in small amounts and handled with caution. 
 
2.10.2 Synthesis of [(FeL)2(µ-OH)]BPh4 via alternate route 
The synthesis of [(FeL)2(µ-OH)]BPh4 was varied slightly to the previously 
published [59]. Fe(ClO4)3·6H2O  (0.143 g, 0.310 mmol) in methanol (1 mL) was added 
to a methanolic solution (10 mL) of ligand (0.117 g, 0.310 mmol) and NEt3 (0.075 g, 
0.691 mmol) and the solution subsequently turned dark wine-red. After stirring for one 
hour at room temperature, solid NaBPh4 (0.160 g, 0.468 mmol) was added and a purple 
precipitate formed immediately. The slurry was refluxed overnight and the purple 
precipitate collected by filtration. The crude powder of [(FeL)2(µ-OH)]BPh4 was 
obtained (180 mg, 94%) after washing with methanol and diethyl ether and drying. 
[(FeL)2(µ-OH)]BPh4·2H2O: C70H75BFe2N6O7 (1234.88): calcd. C 68.08, H 6.12, N 
6.81; found C 68.17, H 5.91, N 6.47. The crude powder was dissolved in CH2Cl2 and a 
small amount of insoluble residue removed by filtration through celite. After pentane 
diffusion into the dichloromethane filtrate, a microcrystalline dark purple solid, 
[(FeL)2(µ-OH)]BPh4·CH2Cl2, was obtained which was collected and dried. This 
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material was suitable for X-ray diffraction. Crystalline [(FeL)2(µ-OH)]BPh4·CH2Cl2: 
C71H73BCl2Fe2N6O5 (1283.78): calcd. C, 66.43; H, 5.73; N, 6.55; found C, 66.81; H, 




) = 496 (7,000) nm. 
 
2.10.3 Titration of [(FeL)2(µ-OH)]BPh4 with Cobaltocene 
Air-free titrations of [(FeL)2(µ-OH)]BPh4 with CoCp2 were monitored by UV-
Vis spectroscopy in MeCN. Solutions of [(FeL)2(µ-OH)]BPh4 (7.3 × 10
-5
 Μ, 3.25 mL) 
in a gas tight cuvette capped with a septum and CoCp2 (2.5 × 10
-3
 Μ, 100 μL) in an 
airtight gas syringe were prepared in a dry box under nitrogen. The CoCp2 solution was 
added in aliquots of 11 μL to the solution of [(FeL)2(µ-OH)]BPh4 and a UV-Vis 
spectrum was collected after each addition. A total of one equivalent reducing agent 
was added to the diiron solution. Subsequently 0.5 mL of oxygen was added to the 
reacted solution and a final spectrum collected (see Figure 2.24). 
 
2.10.4 Synthesis of [(FeL)2(µ-O)]: Reaction of [(FeL)2(µ-OH)]BPh4 with Cobaltocene 
[(FeL)2(µ-OH)]BPh4·2H2O (149.5 mg, 0.121 mmol) was dissolved in CH2Cl2 
(14 mL), and to this stirring solution CoCp2 (23.6 mg, 0.125 mmol) in DCM (1 mL) 
was added. The color changed immediately from dark purple to orange with formation 
of some yellow precipitate. The solution was stirred for 15 more minutes and 
diethylether (30 mL) was added to complete the precipitation. The reaction was worked 
up under air. The yellow ppt (58 mg, 0.114 mmol, 94%) was isolated after filtration and 
identified by NMR as well as X-ray diffraction as CoCp2BPh4. 
1
H NMR (300 MHz, d–
acetone, 293K) δ 5.88 (s, 10H, Cp
–
), 6.78 (t, 4H, p-BPh4), 6.93 (t, 8H, BPh4), 7.34 (m, 
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8H, BPh4). In a different experiment single crystals of CoCp2BPh4 were obtained from a 
dilute reaction solution. 
The filtrate was concentrated in high vacuo and crude powder of [(FeL)2(µ-O)] 
was obtained (110 mg, 0.120 mmol, 99%). [(FeL)2(µ-O)]·2H2O: C46H54Fe2N6O7 
(914.65): calcd. C 60.40, H 5.95, N 9.19; found: C 60.50, H 6.22, N 8.74. Single 
crystals (41%) suitable for X-ray diffraction were obtained after vapor diffusion of 
pentane into acetone solution of crude [(FeL)2(µ-O)]. [(FeL)2(µ-O)]·H2O: 
C46H52Fe2N6O6 (896.63): calcd. C 61.62, H 5.85, N 9.37; found: C 61.63, H 6.08, N 




) = 235 (35,100), 270 (28,000), 420 (7,900) 
nm; (MeCN) = 412 (8,400) nm. FTIR (CH2Cl2):  ̃ = 3686, 3605, 3277, 3048, 2913, 
2860, 1714, 1593, 1566, 1481, 1454, 1359, 1292, 874, 596 cm
–1
; (Nujol): 3250, 3111, 
3057, 2958, 2922, 2851, 1714, 1638, 1593, 1566, 1481, 1454, 1359, 1287, 1225, 1072, 
1013, 879, 757 cm
–1







2.10.5 Synthesis of [(FeL)2] 
NaH (18 mg, 0.750 mmol) in methanol (0.5 mL) was added dropwise to a 
solution of H2L (140 mg, 0.371 mmol) in methanol (4 mL), and stirred for a few 
minutes. FeCl2 (47 mg, 0.371 mmol) in MeOH (0.5 mL) was added dropwise to the 
ligand solution and the color of the solution turned orange-red with some precipitate. 
The solution was immediately filtered through glass wool followed by continued 
stirring of the filtrate. Formation of more precipitate started after 30 min., but the 
solution was allowed to stir overnight to complete precipitation. The precipitate was 
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collected through filtration, washed with methanol and diethyl ether and dried.  A pink 
powder was obtained (110 mg, 0.237 mmol) in 64 % yield. Elemental analysis suggests 
that the crude material is LFe with MeOH as a coordinating solvent (methanol did not 
leave after drying under high vacuum). C24H29FeN3O3 (463.35): calcd. C 62.21, H 6.31, 




) = 471 
(1,000) nm. FTIR (KBr):  ̃ = 3278, 3253, 2857, 1593, 1476, 1450, 1279, 1108, 1032, 
872, 755 cm
–1





Recrystallization of the crude powder was obtained through slow evaporation of a 
MeCN solution to yield [(FeL)2]. 
 
2.10.6 Reactivity of the Diferrous Complex 
A solution of [(FeL)2] in dichloromethane, when exposed to air shifts in UV-vis 
absorption from λmax  = 471 nm to 420 nm , which corresponds to [(FeL)2(µ-O)]. In a 
different experiment, complex [FeL(MeOH)] was created in a methanolic solution in 
situ upon addition of Fe(OTf)2 to a solution of deprotonated ligand (as described in 
Synthesis of [(FeL)2]) and immediately exposed to air. When trying to crystallize the 
reaction product through diethyl ether diffusion, the solution was kept under 







 (0.060 g, 0.128 mmol) was dissolved in a mixture of methanol and 
dichloromethane (3:1 mL) and deprotonated with NEt3 (0.030 g, 0.295 mmol). 
Fe(ClO4)3·6H2O  (0.060 g, 0.130 mmol) in methanol (1 mL) was added to the ligand 
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solution and the solution subsequently turned orange with immediate formation of dark 
brown-orange precipitate. After stirring overnight at room temperature the solid was 
collected by filtration and washed with methanol and diethylether. Crude powder of 
[(FeL
NO2
)2(µ-OH)]ClO4 was obtained (27 mg, 36% yield). [(FeL
NO2
)2(µ-OH)]ClO4· 
2H2O: C46H51ClFe2N10O19 (1195.10): calcd. C 46.23, H, 4.30, N 11.72; found C 46.53, 




) = 380 (54,860) nm. FTIR (KBr):  ̃ 
= 2371, 2345, 1599, 1479, 1436, 1333, 1290, 1119, 1093, 926, 836, 784, 759, 669 cm
–1
. 









Crystalline material of [(FeL
NO2
)2(µ-OH)]ClO4 was obtained upon diffusion of CH2Cl2 
into a solution of crude material in MeCN. 
 
2.10.8 X-ray Crystal Structure Determination  
X-ray quality crystals of [(FeL)2(µ-OH)]BPh4·CH2Cl2 were obtained by 
diffusion of pentane into a methylene chloride solution of [(FeL)2(µ-OH)]BPh4. Single 
crystals of [(FeL)2(µ-O)] were obtained by slow evaporation of pentane into an acetone 
solution of [(FeL)2(µ-O)]. Single crystals of [(FeL)2] were obtained by slow evaporation 
of an acetonitrile solution of [(FeL)2]. Single crystals of [(FeL
NO2
)2(µ-OH)]ClO4 were 
obtained by slow evaporation of methylene chloride into a solution of [(FeL
NO2
)2(µ-
OH)]ClO4 in acetonitrile. Intensity data for all the compounds were collected using a 
diffractometer with a Bruker APEX ccd area detector [82, 83] and graphite-
monochromated Mo-Kα radiation (λ = 0.71073 Å). The samples were cooled to 100(2) 
K. Cell parameters were determined from a non-linear least-squares fit of the data. The 
data were corrected for absorption by the semi-empirical method [84]. The structure 
91 
was solved by direct methods and refined by full-matrix least-squares methods on F
2
 
[85, 86]. Hydrogen atom positions of hydrogen atoms bonded to carbon atoms were 
initially determined by geometry and were refined by a riding model. Hydrogen atoms 
bonded to nitrogen or oxygen atoms were located on a difference map, and their 
positions were refined independently. Non-hydrogen atoms were refined with 
anisotropic displacement parameters. Hydrogen atom displacement parameters were set 
to 1.2 (1.5 for methyl) times the displacement parameters of the bonded atoms. Crystal 
data for [(FeL)2(µ-O)]·(C3H6O)2∙(H2O), [(FeL
NO2
)2(µ-OH)]ClO4·(H2O)∙(C2H3N)∙ 
(CH2Cl2) and [(FeL)2]·(CH4O)2 are summarized in Table 2.5. Selected bond lengths and 
angles for [(FeL)2(µ-O)], [(FeL
NO2
)2(µ-OH)]ClO4 and [(FeL)2] are summarized in Table 




































formula C52 H64 Fe2 N6 O8 C48H58Fe2N6O6 C49H54Cl3Fe2N11O18 
fw 1012.79 926.70 1303.08 
Crystal system triclinic monoclinic monoclinic 
Space group P1 
 
P21/n P21/n 
a (Å) 11.074(2) 12.8640(18) 11.9637(6) 
b (Å) 12.872(2) 13.4112(19) 20.2286(11) 
c (Å)  17.425(3) 13.0923(19) 22.2512(12) 
α (deg) 84.588(4) 90 90 
β (deg) 86.831(4) 103.606(3) 95.204(2) 
γ (deg) 83.527(5) 90 90 
V (Å
3
) 2454.5(7) 2195.3(5) 5362.8(5) 
Z 2 2 4 
ρcalcd (mg/m
3
) 1.370 1.402 1.614 
μ (mm
–1
) 0.652 0.718 0.777 







0.0502, 0.1231 0.0504, 0.1104 0.0493, 0.1212 
GOF on F
2 
1.017 1.006 1.004 
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Copper(II) Complexes of Symmetric and Asymmetric Bis(imine) 








Copper is one of the most abundant redox active metals and plays an important 
role in many biological processes [1], which were introduced in chapter 1. Herein the 
focus will be on electronic tuning of the copper ion. While copper(II) ions prefer a 
square planar geometry, copper(I) complexes are usually found in tetrahedral 
coordination environments. This trend is explained fairly easily when the degeneracy of 
the 3d-orbitals in different geometrical fields and crystal field stabilization energies are 
considered (see Figure 3.1). In the configuration of d
9
 (Cu(II)), the more favorable 
geometry is square planar. The crystal field stabilization energy for square planar 
geometry is lower (–1.21 Δo) versus –0.4 Δt (or for comparison = –0.18 Δo) for 
tetrahedral geometry, therefore being more stable. (Relative energy values of the 3d-
orbitals in crystal fields of different symmetry are taken from reference [2] and [3] for 
Td and square planar, respectively; Δt and Δo can be interconverted via the relationship Δt 
= 4/9 Δo [2].) 
 
Figure 3.1. Schematic representation of the crystal field splitting for tetrahedral and 
square planar geometry. 
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The copper(I) ion has a d
10
 configuration and does not result in energy gain upon 
distortion of the geometry. The most favorable geometry for a metal ion with four 
ligands is tetrahedral, only considering ligand-ligand interactions to produce a complex 
where all donors are farthest apart. This is consistent with the VSEPR model for a 
central atom with four substituents.  
In nature, blue copper electron transfer proteins use copper as a one electron 
relay to shuttle between the cupric (Cu(II)) and cuprous (Cu(I)) oxidation states [4]. The 
coordination geometry in some of these proteins is strained between square planar and 
tetrahedral which lowers the redox barrier because the reorganization energy 
(geometrical change and change in bond lengths) upon reduction/oxidation is lowered 
[5]. A crystal structure of the active site of plastocyanin, a blue copper protein, is shown 
below in Figure 3.2. A more detailed background on blue copper proteins is given in 
chapter 4. 
 
Figure 3.2. a) Protein structure of plastocyanin and b) the amino acid residues 
surrounding the copper ion. Figure is adapted from reference [6]. 
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While most blue copper proteins are very similar in structure and geometry [5], 
metal center redox potential fine tuning can still be achieved. It was shown that in 
azurin (a blue copper protein) secondary interactions can influence the redox potential 
of the Cu(II)/Cu(I) couple. Hydrogen bonding and hydrophobicity can cause a change 
in potential up to 700 mV without perturbation of the metal binding site [7]. The tuning 
of the Cu(II)/Cu(I) redox couple is a critical component of electron transfer in blue 
copper proteins, and is also important in synthetic complexes where copper plays a role 
as the redox center in catalysis. The relationship between redox potential and structure 
has therefore received considerable attention for many years [8-12]. The effect of tuning 
the redox potential in catalysis to influence reactivity and selectivity was shown by 
Jacobsen [13]. Das et al. have reported the change in reactivity of a copper complex 
towards aerobic oxidation of alcohols by electronic tuning [14]. 
In the following sections it will be discussed how synthetic metal complexes can 
be electronically tuned. While geometric constraints, e.g. tetrahedral versus square 
planar, already discussed above, are of great importance, ligand donor atoms are also a 
key factor in redox potential control. Sigma- and pi-donor ligands push more electron 
density on the metal ion, moving the Cu(II)/Cu(I) redox potential to lower (more 
negative) potentials [15-17]. Sigma-donors stabilize the higher oxidation state of the 
metal ion by donation of electron density while pi-acceptors stabilize the metal ion in its 
lower oxidation state by pulling electron density off the metal ion. 
 This chapter will be focused on copper complexes with chelating Schiff base 
ligands. Schiff bases are important ligands because of their synthetic simplicity and the 
diversity of possible ligands owing to the mix-and-match ability of the condensation of 
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various amines with different aldehydes. In particular, tetradentate Schiff base ligands, 
including salen and its derivatives, have been used for a wide variety of coordination 
chemistry with copper and other transition metals [18-25]. Salen ligands are derived 
from ethylenediamine, and typically salen corresponds to the condensation product of 
ethylenediamine and two equivalents of 2-hydroxybenzaldehyde. On the other hand, 
salen-type ligands can have any amine linker R
1
 but still show the [O,N,N,O]-donor 
manifold and thus form tetradentate bis-Schiff bases [26], [27] (see Figure 3.3).  
 
Figure 3.3. Salen and most common salen-type ligands. R
2
 represents possible 
substitution on the aromatic ring. 
 
The syntheses of tetradentate Schiff base ligands are versatile due to their 
modular nature (see Figure 3.4). An alkanediamine backbone starting material can 




Figure 3.4. General structure of copper(II) complexes with tetradentate Schiff base 
ligands. X, Y = donor group (e.g. pyridyl or phenolate), Z = counterion in axial position 
and n = number of -(CH2)- units. 
 
 Examples of how different tetradentate Schiff base donors influence the 
Cu(II)/Cu(I) redox potential of their corresponding complexes have been reported in the 
literature [24, 28-31]. It has been shown that the length of the alkane chain of the 
diamine unit plays an important role in the redox behavior of the metal ion [28], as this 
type of ligand variation selects for different coordination geometries [29], (e.g. 
tetrahedral versus square planar). Crystal structures of copper(II) complexes with 
ligands of varying chain length within the diamine unit and X = 2-hydroxybenzyl 
(Figure 3.4) were reported in the past and show distortion of the coordination geometry 
from n = 2 being square planar towards n > 2 showing increased distortion towards 
tetrahedral with increasing chain length. When n = 5 (see Figure 3.5) or 6, dimeric 
square planar, complexes are obtained and no geometrical strain around the copper ion 
is observed [29].  
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Figure 3.5. Schematic depiction of coordination of Cu(II) ions by a salen-type ligand 
with pentyldiamine. 
 
When X = pyridyl (Figure 3.4) and the chain length of the diamine is varied 
from propyl to hexyl, the redox potential for the copper ion is shifted towards more 
positive potentials (with an overall shift of 210 mV) [28]. This seems reasonable 
because the increase in chain length, like shown in ref. [29], does favor tetrahedral 
distortion of the complex, thus allowing for easier reduction of the copper(II) ion. 
In a different study, variation of the weakly coordinated counterion in the axial 
position of the quadridentate Schiff base copper complex was shown to influence the 
electrochemistry of the copper redox couple [30].  
 
Figure 3.6. Ligand (left, representing N1–N4) and copper(II) complexes with different 






. Figure is redrawn from reference [30]. 
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The copper(II) complex with two perchlorate counter ions (see elongated 
octahedral structure in Figure 3.6) is easily modified to other complexes via counter ion 






. This causes 
rearrangement in geometry from Jahn-Teller distorted octahedral to trigonal 
bipyramidal. Electrochemical studies show shifts in the redox potential for the copper 
ion within a range of 240 mV depending on the counter ion. The nitrite ion causes the 
most rearrangement towards trigonal bipyramidal and therefore the largest shift of the 
redox potential towards more negative potentials. 
Although diamines should allow stepwise condensation of two different 
aldehydes and therefore more variation, not much has been reported on the 
electrochemistry of copper complexes with asymmetric ligands. Ghosh and coworkers 
have shown that the mono-condensed product of 1,3-propanediamine and 1-
benzoylacetone generated via the high dilution method can be used as a precursor for 
condensation with 2-pyridinecarboxaldehyde or 2-acetylpyridine to form asymmetric 
ligands (see Figure 3.7a, b) [31]. Although the ligands were not isolated, copper 
complexes with the ligands were isolated and studied. 
 
Figure 3.7. Asymmetric and symmetric ligands derived from 1,3-propanediamine and 
1-benzoylacetone reported in reference [31]. 
 
The asymmetric copper complexes with ligand a and b show drastic shifts in 
redox potentials (about 400 mV) of the copper ion towards more negative potentials 
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compared to the symmetric condensation product of 1,3-propanediamine with two 
equivalents of 1-benzoylacetone (see Figure 3.7c) [31]. The authors believe that the 
change in redox potential is also influenced by geometrical strain towards tetrahedral 
for the complex with the symmetric ligand c. Another asymmetric system was 
introduced to the literature by the same group, again using the high dilution method 
[24]. The asymmetric copper complex of the 1:1:1 condensation of 1,3-propanediamine, 
2,4-pentanedione and 2-pyridinecarboxaldehyde showed irreversible reductions and the 
copper complexes readily reorganized into their symmetric complexes in the presence 
of catalytic amounts of acid and copper(II) ions (see Figure 3.8) [24].  
 
Figure 3.8. Decomposition of the asymmetric copper complex into the symmetric one 
upon addition of free copper(II) ions or acid. Figure is redrawn from reference [24]. 
 
In the following section some concepts of asymmetric Schiff base ligand design 
will be discussed. The isolation of copper(II) complexes of these asymmetric ligands 
would allow for fine tuning of the redox potential and access to intermediate redox 
potentials. Generally, there are three ways of breaking the symmetry in salen-type 




Figure 3.9. Possible derivatization of salen-type ligands to obtain asymmetric 
tetradentate Schiff bases. Figure is adapted from reference [32]. 
 
Most common is the synthesis of salen-type ligands with asymmetric diamines 
like 1,2-diaminocyclohexane (Figure 3.9A). Complexes with this ligand are well known 
in the literature. Jacobsen’s catalyst is the complex with M = manganese and has been 
used in asymmetric expoxidation catalysis [33]. Ito and Katsuki reported another A-type 
complex (Figure 3.10, complex 4) [34]. Complexes with B-type ligands are generated 
with the use of special strategies. Some examples were mentioned earlier (see Figure 
3.7) where high dilution techniques yield asymmetric complexes. Another example is 
shown below (Figure 3.10, complex 5), which was also introduced by Jacobsen [35] . 
 
Figure 3.10. Asymmetric complexes used in catalysis. Figure is adapted from reference 
[32]. 
 
The general issues with the synthesis of asymmetric complexes are acid 
promoted equilibration of the asymmetric ligand to the symmetric versions (see Scheme 
3.1) and contamination with symmetric diimine and free amine in the step-wise 
condensation with two aldehydes (see scheme 3.2). 
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Scheme 3.1. Equilibrium between asymmetric and symmetric diimes. Figure is adapted 
from reference [32]. 
 
 
Scheme 3.2. Equilibrium between mono-, diimine and free amine. Figure is adapted 
from reference [32]. 
 
The group of Gilheany studied the synthesis of asymmetric complexes of type C 
(Figure 3.9C) and developed a strategy for the generation of complex 6 (see Figure 
3.10) [32]. The key idea was to isolate the monoimine with the use of a tartaric acid to 
form an ammonium tartrate salt and then add one equivalent of a different aldehyde to 
form the asymmetric Schiff base.  
In this chapter a strategy for the synthesis of 1,3-propylenediamine derived 
asymmetric Schiff bases will be discussed (see 3.2). The synthesis of two new ligands is 
presented (one of them being asymmetric) and difficulties in purification will be 
discussed.  The formation of two new copper(II) complexes with these ligands is shown 
in part 3.3. Also, the spectroscopic and electrochemical properties of the asymmetric 





In this chapter the electrochemical properties of copper(II) complexes of three 






 are contrasted. Recently the 
synthesis of a symmetric Schiff base ligand H2L
1
 (Figure 3.11), derived from 2-methyl-
2-pyridin-2-yl-propane-1,3-diamine (ppda) and 2-hydroxybenzaldehyde was reported 
by the Houser group [36]. Herein, the synthesis of the more electron deficient 
bis(pyridyl) bis(imine), L
3
, and the asymmetric hybrid version containing both a pyridyl 
group and a phenol group, namely HL
2
 are reported (see Figure 3.11). The latter ligand 
allows access to intermediate electronic properties between the two strictly symmetric 
ligands. 
 
Figure 3.11. Structures of the previously synthesized ligand H2L
1











 can be obtained by addition of two equivalents of the 
respective aldehyde to ppda, there are challenges in the synthesis of asymmetric ligands 
like HL
2
, such as the step-wise condensation of different aldehydes with the diamine 
starting material. Some examples of asymmetric bis(imine) and bis(amine) ligands, as 
well as their metal complexes can be found in the literature [37-41]. An additional 
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difficulty that must be taken into account in the step-wise condensation of 1,3-
propanediamine units with two different aldehydes is the tendency in formation of 
hexahydropyrimidines (through cyclization) with the first equivalent of aldehyde [42]. 
The advantage of the cyclization, though, is the directed yield in mono condensed 
products over a mix of doubly condensed and unreacted species. The most challenging 
aspect is the hydrolysis of asymmetric bis(imine)s followed by condensation to their 
symmetric analogues. However, this problem can be overcome by metal chelation, 
which prevents decomposition and rearrangement. 
 In the next part the strategy for synthesizing HL
2
 will be further explained. 
Locke and coworkers have shown that electron-rich aldehydes like 2-
hydroxybenzaldehyde shift the equilibrium towards bis(imine) formation when 1,3-
propanediamine is used [42]. Therefore, if one would just add one equivalent of each, 
ppda, 2-pyridinecarboxaldehyde and 2-hydroxybenzaldehyde, the expected products 
would be mostly the salen-type Schiff base (condensation with the benzaldehyde). Even 
with the use of only one equivalent 2-hydroxybenzaldehyde, bis(imine) formation is 
favored [42]. However, when one equivalent of 2-pyridinecarboxaldehyde, an electron-
poor aldehyde, is added to 1,3-propanediamine, the formation of a hexahydropyrimidine 
ring is observed rather than imine production [42]. A summary of the condensation 
products using 1,3-propamediamine with selected aromatic aldehydes is given in the 




Figure 3.12. Reaction of 1,3-propanediamine with various aromatic aldehydes. 
Figure is adapted from reference [42]. 
 
According to the previous work published, it should be possible to first generate 
the hexahydropyrimidine species upon addition of one equivalent 2-
pyridinecarboxaldehyde to ppda, then HL
2
 should be obtained upon reaction with one 
equivalent of 2-hydroxybenzaldehyde. The synthesis plan is shown in Figure 3.13. 
 




In the following, the synthesis of the ligands, including a discussion of their 
stability, will be given in 3.3 (see sections 3.3.1 and 3.3.2). The results of the copper 
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complexes are discussed in part 3.4 (including the syntheses of the copper complexes in 
3.4.1,  sections 3.4.2–3.4.4 will deal with the properties of the copper(II) complexes, 




3.3.1 Syntheses of Ligands 
 The previously reported ligand H2L
1
 (Figure 3.11) was prepared through Schiff 
base condensation of ppda with two equivalents of 2-hydroxybenzaldehyde, and 





 (see Figure 3.11) were synthesized in this work. HL
2
 is a potentially 
monoanionic ligand with an N4O donor set, whereas L
3





 were synthesized via condensation of ppda with one equivalent each of 2-
pyridinecarboxaldehyde and 2-hydroxybenzaldehyde, or two equivalents of 2-





 in high purity.  
 Attempts to purify L
3
 through chromatography (silica, CH2Cl2:CH3OH, 95/5%) 
resulted in its decomposition. The two collected fractions were identified as one of the 
starting materials, 2-pyridinecarboxaldehyde, and a mixture of compounds (the majority 
being most likely the cis and trans isomers of the hexahydropyrimidine L
4
: see Scheme 
3.1 and the 
1





H NMR of L
4
 (300 MHz, CDCl3, 293K), isolated after chromatography of 
L
3
. (Expanded view of the 1–5 ppm region of the spectrum with peak assignments of 






H NMR spectrum of L
4
 shown in Figure 3.14 shows two sets of protons 
(one set labeled in green, the other one in blue). The integration of each set of signals 
matches a 3:2:2:1 ratio for Me:CH2:CH2:CH of the hexahydropyrimidine ring. Aromatic 
peaks are omitted for clarity. The ratio of one set of peaks to the other set is about 30% 
to 70%. This indicates that one isomer is preferred over the other one. It is possible that 
the hexahydropyrimidine is in equilibrium with the mono-imine form, allowing for 
conversion between the cis and trans isomers. This hypothesis will be discussed in 
section 3.3.2 and suggestions for the structure of the conformers will be made. 




 decompose in solution 
over time, to 2-pyridinecarboxaldehyde and possibly the hexahydropyrimidine species, 
which was indicated by the growth in the 
1
H NMR spectrum of the aldehydic proton of 
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2-pyridinecarboxaldehyde signal, and the appearance of additional signals in the 
methyl, methylene and aromatic regions. 
1







, taken immediately and taken after four days are shown in the following Figures 
3.15, 3.16 and 3.17, respectively. The spectrum of H2L
1
 only shows a growth in the 








H NMR of H2L
1
 (300 MHz, CDCl3, 293K), bottom: freshly prepared 
solution of H2L
1




Figure 3.16. a) 
1
H NMR of HL
2
 (300 MHz, CDCl3, 293K), bottom: freshly prepared 
solution of HL
2
; top: NMR retaken after four days. Hydrolysis product peaks are circled 





The incoming aldehyde peak at around 10.2 ppm in Figure 3.16a after 4 days 
suggests that 2-pyridinecarboxaldehyde is released, rather than 2-hydroxybenzaldehyde 
(smaller peak at around 9.8 ppm). 
In contrast to the 
1
H NMR of HL
2
, taken immediately (Figure 3.16a), which 
looks very clean and therefore indicates high purity of the ligand, L
3
 cannot be obtained 
in very high purity. Figure 3.17a shows a small amount of free aldehyde and extra peaks 
in the methyl, and methylene region which indicate impurities. These peaks increase in 
intensity upon hydrolysis. These results are consistent with the work done by Locke, 
where 34% of hexahydropyrimidine was found upon reaction of 1,2-propanedimamine 
with two equivalents of 2-pyridinecarboxaldehyde [42]. The 
1
H NMR spectrum 
obtained from decomposition of L
3
 looks similar to the 
1
H NMR spectrum obtained 





Figure 3.17. a) 
1
H NMR of L
3
 (300 MHz, CDCl3, 293K), bottom: freshly prepared 
solution of L
3
; top: NMR retaken after four days. b) Expanded view of the 1–5 ppm 




Figure 3.18. a) 
1
H NMR of crude L
4
 (300 MHz, DMSO-d
6
, 293K) after reaction of 
ppda with 1 eq of 2-pyridinecarboxaldehyde. b) Expanded view of the 1–5 ppm region 







3.3.2 Confomers of the Hexahydropyrimidine Molecule 




are in good agreement 
with recently published work on the formation of bis(imine)s and hexahydropyrimidines 
via the condensation of 1,3-propanediamine with various aldehydes (Figure 3.12) [42]. 
When two equivalents of aldehyde were used, the product was always the bis(imine), 
except in the case of 2-pyridinecarboxaldehyde about 34% of hexahydropyrimidine was 
found. 
Also, the potential for the formation of intramolecular hydrogen bonds between 
the phenol hydrogen atoms and the imine nitrogen atoms in H2L
1
 may stabilize the 
bis(imine), while L
3
 cannot develop similar hydrogen bonding, see below in Figure 
3.19. 
 




Unlike in a cyclohexane chair conformation, the hexahydropyrimidine ring does 
not show typical 1,3 diaxial interactions of the substituents. Instead pyridine 
substituents favor hydrogen bonding from the pyridine N-atom to the N-H of the 
hexahydropyrimidine. This interaction has been shown previously in similar structures 
with the ppda backbone [43, 44]. In crystal structures published by Grohmann et al., the 
pyridine N-atom hydrogen bonds to the axially oriented N-H group of the ring (see 
Figures 3.20 and 3.21). 
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Figure 3.20. Hydrogen bonding between N11 and H3-N3. Figure is adapted 
from reference [43]. 
 
 
Figure 3.21. Hydrogen bonding between N10 to H33-N33. Figure is adapted 
from reference [44]. 
 
The two structures reported previously support the suggested structure shown in 
Figure 3.22. The pyridine substituent should be in the axial position and hydrogen 




Figure 3.22. Possible hydrogen bonding of the ppda-Pyridine-N atom to the 
axial standing N-H of the hexahydropyrimidine. 
 
Now the question arises of where the other pyridine ring would most likely be 




? A recent publication shows the crystal 
structure of a pyridine substituted hexahydropyrimidine (Figure 3.23).  According to the 
schematic depiction in 3.22 the pyridine substituent is found at the R
2
 or axial position 
and the equatorial N-H is forming a hydrogen bond to the N-atom of pyridine [45].  
 
Figure 3.23. Crystal structure of a pyridyl-hexahydropyrimidine. Figure is 
adapted from reference [45]. 
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Combining all information, the structure depicted below (Figure 3.24) should lead to the 
most stable structure with the two pyridine rings in axial position and therefore the 
trans-conformation of the molecule. 
 
Figure 3.24. Most stable structure for L
4
, trans conformer. 
 
Theoretical studies carried out on hexahydropyrimide further support the 
hypothesized structure. According to Salzner, the hexahydropyrimidine having N-H in 
the axial/equatorial (ae) and axial/axial (aa) position is energetically favored, while the 
equatorial/equatorial (ee) position is less likely to form (see structures below in Figure 
3.25). 
 
Figure 3.25. Conformers of hexahydropyrimidine. 
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The trans conformation of L
4
 is in equilibrium with the open, monoimine form, 
and ring closure to the cis conformer is possible by nucleophilic attack from the other 
side. In fact, a peak for the imine is seen in the 
1
H NMR spectrum together with 2 sets 
of protons, one for the trans and the other one for the cis form (see Figure 3.14). 
Tautomerism between all forms of L
4
 is shown in figure 3.26. 
 
Figure 3.26. Tautomerism between the cis and trans isomers of the 




3.4 Synthesis of the Copper Complexes 




, it was possible to obtain pure metal 
complexes of the two ligands upon coordination to copper(II) salts. A methanolic 









)](ClO4)2 as olive-green and light blue precipitates, 













Cu(ClO4)2·6H2O; (b) 1 eq 2-pyridinecarboxladehyde, 1 eq 2-hydroxybenzaldehyde; (c) 
2 eq 2-pyridinecarboxladehyde; (d) column chromatography on silica, or decomposition 




)](ClO4)2 was also obtained when L
3
 was generated in situ from L
4
 in 
solution, along with one equivalent of 2-pyridinecarboxaldehyde followed by 
subsequent addition of cupric perchlorate as shown in Scheme 1-f. Crystals suitable for 
X-ray structural analysis were obtained after recrystallization of the powders. The solid 
state structures will be discussed in 3.4.2. [Cu(HL
2
)]2(ClO4)4 was found in the solid 




 subunits where the proton on the 
phenol group has migrated to the pyridyl N atom. The ligand in [Cu(HL
2
)]2(ClO4)4 is 
therefore still neutral despite the deprotonated phenolate due to the protonated 
pyridinium group. In contrast to [Cu(HL
2
)]2(ClO4)4, the complex with L
3
 was isolated 
as a monomer [Cu(L
3
)](ClO4)2. Solutions of [Cu(HL
2
)]2(ClO4)4 in methanol and 
acetonitrile seem to dissociate into monomers as ascertained by the solution magnetic 
moment and mass spectrometry. Low intensity peaks in the ESI-MS show a small 
amount of dimer present, as well as monomer with solvent coordinated. Additionally, 
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EPR and CV data indicate that there may be small amounts of dimer in solution (see 
Sections 3.4.3 and 3.4.4, respectively). Unfortunately, due to solubility constraints in 
non-coordinating solvent it was not possible to study the nature of the dimer in solution. 
 
Figure 3.27. Structures of the copper imine complexes discussed in this work. The 
synthesis and structure of [Cu(L
1
)(CH3OH)] was reported previously [36]. 
[Cu(HL
2







)](ClO4)2 is a monomer in solution. 
 




 by the deprotonation of HL
2
 were unsuccessful. 
The potentially monoanionic ligand HL
2
 was treated with base either before or after the 





Addition of base to the ligand in methanol with subsequent complexation of copper(II) 
ions resulted in an accumulation of a mixture of a green and blue precipitate. According 




)](ClO4)2 were present 
in this mixture. Upon recrystallization of the crude powder, crystals of [Cu(L
3
)](ClO4)2 
were obtained. When complex [Cu(HL
2
)]2(ClO4)4 was treated with two equivalents of 
base (or water) in acetonitrile, no ligand rearrangement was observed according to mass 
spectrometry. Diffusion of diethyl ether into a solution of [Cu(HL
2
)]2(ClO4)4 in CH3CN 
and NEt3 did not form any crystalline material. The use of base before complex 









was unsuccessful, despite HL
2
 being stable towards decomposition and/or 
rearrangement of the arms when coordinated to the metal ion. 
 
3.5 X-ray Crystal Structures 
 The previously published structure of [Cu(L
1
)(CH3OH)] (Figure 3.28) revealed 





 ligand in the equatorial plane and an axial O atom from a coordinated 
methanol molecule [36]. The pyridyl group does not coordinate in [Cu(L
1
)(CH3OH)], 
most likely due to geometric constraints that the bis(imine) ligand imposes on the 
complex. Compared to similar ligands with amine functional groups [43, 46], the more 
planar geometry imposed by the ligand due to the imine C-N double bonds in 
[Cu(L
1
)(CH3OH)]  prevent the pyridyl N atom from folding into position where it can 





)](ClO4)2 (vide infra).  
 
Figure 3.28. Representation of the X-ray structure of [Cu(L
1
)(CH3OH)] with H atoms 
removed for clarity. Figure is adapted from reference [36]. 
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 According to the X-ray crystal structure of [Cu(HL
2
)]2(ClO4)4 (Figure 3.29), 
each copper(II) ion is coordinated in a square pyramidal geometry with a τ5 parameter 
[47] of 0.024 (Figure 3.29). The N3O donor atom set from the ligand occupies the basal 
plane of the pyramid with the μ2-phenolato O atom from another complex coordinating 
in the apical position. The resulting structure contains two copper ions with bis(μ2-O) 
bridging phenolate groups in a diamond core fashion. The apical O atom bond donor 
distance to the copper ion (Cu–O1#1 = 2.487 Å) is longer than the basal donors 
(ranging from 1.922 to 2.020Å) due to the Jahn-Teller effect. The pyridyl ring from the 
ligand backbone is non-coordinating and, surprisingly, protonated at the N atom 
position. The overall +4 charge is balanced by four perchlorate counterions (Figure 
3.29), two of which are weakly interacting with the copper(II) in the apical position 
trans to the phenolate O atom of each monomeric unit (Cu···O = 2.763 Å), while the 
other two are non-coordinating. Hydrogen bonding between the pyridinium hydrogen 
and the non-coordinating methanol oxygen atom (N14–H14···O1S), as well as between 
the perchlorate ion oxygen and the methanol hydrogen atom (O1S–H1S···O1A#2), 
stabilizes the structure in the solid state (Figure 3.30, Table 3.2).  
 A complex similar to [Cu(HL
2
)]2(ClO4)4 was reported by Lee and coworkers 
with the ligand N-(salicylidene)-N'-(2-pyridylaldene)propanediamine [25]. This ligand 
differs from HL
2 
only in the absence of the methyl and pyridyl groups on the propylene 
backbone. [Cu(HL
2
)]2(ClO4)4 adopts the same Cu2(μ-phenolato)2 diamond core, and has 
the same N2O donor atom set as the complex with N-(salicylidene)-N'-(2-
pyridylaldene)propanediamine [25]. Since HL
2 
and N-(salicylidene)-N'-(2-
pyridylaldene)propanediamine are effectively the same except for the pyridine group, 
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both ligands coordinate in the same fashion, and the ligand-copper bond lengths and 
angles are very similar [25].  
 




 with all H atoms 
except for the protonated pyridyl NH protons removed for clarity. Perchlorate anions 
and methanol solvent of crystallization molecules are also removed for clarity. 




Figure 3.30. Representation of the X-ray structure of [Cu(HL
2
)]2(ClO4)4 including 
solvent molecules and anions with intermolecular H-bonding represented by light blue 
dashed lines. 
 
 The X-ray structure of [Cu(L
3
)](ClO4)2 consists of a mononuclear copper(II) 
complex of L
3
 and two perchlorate anions (Figure 3.31). The coordination geometry in 
[Cu(L
3
)](ClO4)2 is axially elongated six-coordinate tetragonal. The L
3 
ligand 
coordinates in a slightly distorted square planar (τ4 = 0.154) [48] manner while the 
perchlorate oxygens are weakly coordinating in the axial positions (Cu1–O1A = 2.660 
Å and Cu1–O1B = 2.573 Å). As observed in other Cu(II) complexes with our bis(imine) 
family of ligands, here the ligand backbone pyridine nitrogen atom is non-coordinating. 
The geometrical constraints imposed by the ligand prevent the pyridyl ring from getting 
close enough to coordinate to the copper ion. As in [Cu(HL
2
)]2(ClO4)4, there is 
significant bond elongation between the copper(II) ion and the axial donor atoms versus 
the donors in the basal plane.  
 A complex similar to [Cu(L
3
)](ClO4)2 was reported by Ray and coworkers with 





 and N,N'-bis(2-pyridylaldene)propane-1,3-diamine coordinate via the same 
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N4 donor atom set. Both complexes show the same N4 coordination mode, with similar 
ligand-copper bond lengths and angles, due to the ligands sharing same ligand backbone 
and the fact that the pyridyl group of L
3
 does not coordinate the copper atom. 
 




 with all H atoms 








 have a common coordination mode to copper(II) ions. While 
the pyridine nitrogen atom of each ligand backbone is non-coordinating, the remaining 
N and O donors chelate in the basal plane around the metal ion (see Figure 3.27). The 
pyridyl ring does not coordinate in all three complexes presented because of geometric 






. This stands in 
contrast to copper complexes of the more flexible series of bis(amine) ligands 
synthesized in our laboratory [46]. The geometry of [Cu(L
1
)(CH3OH)] is similar to 
[Cu(HL
2
)]2(ClO4)4 but features a CH3OH oxygen donor atom (not shown in Figure 
3.27) in the axial position rather than a bridging phenolate. Therefore, 
[Cu(L
1









)(CH3OH)] and 2.49 Å for [Cu(HL
2
)]2(ClO4)4) compared to the basal donors, 
averaging in metal-ligand atom bond distances from 1.92 Å to 2.02 Å. Although 
[Cu(L
3
)](ClO4)2 was synthesized in CH3OH and crystallized from CH3CN, no solvent 
molecule occupies the axial position. Instead, perchlorate anions are found in weak 
association to the metal ion in the axial positions (2.57 Å and 2.66 Å).  





summarized in Table 3.1. Hydrogen bonding information of [Cu(HL
2
)]2(ClO4)4 is 





summarized in Table 3.4. 
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)]2(ClO4)4    
Cu1-O1 1.922(2) Cu1-N9 1.956(3) 
Cu1-N20 2.020(2) Cu1-N27 2.010(3) 
Cu1-O1#1 2.487(2) Cu1-O2A 2.763(3) 
O1-Cu1-N9 94.22(9) O1-Cu1-N27 91.35(9) 
N9-Cu1-N20 93.97(9) N27-Cu1-N20 80.94(9) 
N9-Cu1-N27 169.94(9) O1-Cu1-N20 171.38(9) 
O1-Cu1-O1#1 82.52(8) N27-Cu1-O1#1 89.87(8) 
N9-Cu1-O1#1 99.14(8) N20-Cu1-O1#1 93.55(8) 
[Cu(L
3
)](ClO4)2    
Cu1-N19 1.966(2) Cu1-N8 1.996(2) 
Cu1-N1 2.018(2) Cu1-N22 2.050(2) 
Cu1-O1B 2.573(2) Cu1-O1A 2.660(2) 
N19-Cu1-N8 91.65(9) N19-Cu1-N1 168.37(9) 
N8-Cu1-N1 82.63(9) N19-Cu1-N22 81.35(9) 
N8-Cu1-N22 169.95(9) N1-Cu1-N22 105.50(9) 
N19-Cu1-O1B 106.80(9) N8-Cu1-O1B 85.17(8) 
N1-Cu1-O1B 82.89(9)   




Table 3.2. Hydrogen bonds (Å) and angles (deg) for [Cu(HL
2
)]2(ClO4)4. 
D-H···A d(D-H) d(H···A) d(D···A) <(DHA) 
N14-H14···O1S 0.83(3) 2.01(3) 2.764(3) 151(3) 
O1S-H1S···O1A#2 0.74(4) 2.24(4) 2.864(3) 144(4) 
Symmetry information used to generate equivalent positions: (–x + ½, –y + ½, –z). 
 
3.6 Spectroscopic Characterization 
 Electrospray mass spectrometry suggests that CH3OH and CH3CN solutions of 
[Cu(HL
2










are indicative of monomeric species. A peak with very low intensity 






indicating a dimeric species, was also 
detected. This dissociative behavior in solution is further supported by a solution 
magnetic moment of 1.76 µB/Cu. This magnetic moment, which is close to the spin-
only value of 1.73 µB/Cu, suggests the absence of any magnetic coupling and therefore 
supports the existence of a monomeric species in solution. 
 [Cu(HL
2
)]2(ClO4)4 was dissolved in methanol at room temperature to allow 
equilibration and subsequently frozen. EPR spectra show two sets of peaks, which 
originate from two typical axial EPR signals (Figure 3.32, red). Those two sets of 





)]2(ClO4)4, respectively). Due to differences in the coordination environment 
around the copper ions between the monomer and the dimer, it is expected to see 
differences in g values and therefore two sets of axial EPR signals. To further support 
this hypothesis, solutions of [Cu(HL
2
)]2(ClO4)4 were allowed to equilibrate in a dry 
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ice/acetone bath for two hours before freezing the sample in liquid nitrogen. The 
corresponding EPR spectrum (Figure 3.32, black) only shows one set of signals which 





Figure 3.32. EPR spectra of frozen solutions of [Cu(HL
2
)]2(ClO4)4 (9.466 GHz, mod. 
amp. 25.0 G, CH3OH, 77K). Black: [Cu(HL
2
)]2(ClO4)4 in CH3OH was kept in an EPR 
tube for two hours in a dry ice/acetone bath before subsequent freezing in liquid 
nitrogen and acquisition of the spectrum, red: [Cu(HL
2
)]2(ClO4)4 was dissolved in 
CH3OH at room temperature before subsequent freezing in liquid nitrogen and 
acquisition of the spectrum. 
 
 Frozen solutions of [Cu(HL
2
)]2(ClO4)4 in CH3CN only show one axial EPR 
signal. [Cu(HL
2
)]2(ClO4)4 has a much greater solubility in CH3CN than in CH3OH and 
due to the solubility difference it is reasonable to assume that [Cu(HL
2
)]2(ClO4)4 
dissociates immediately in CH3CN. The slight shift in g for the monomers is likely due 
to solvent coordination (CH3OH vs. CH3CN). 
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 CH3CN solutions of [Cu(L
3
)](ClO4)2 were found to contain monomeric species, 





) and solution magnetic moment measurements (1.75 µB/Cu). 
[Cu(L
3
)](ClO4)2 likewise possesses an axial EPR spectrum. 
 
3.7 Electrochemical Studies 




)](ClO4)2 were studied by 
cyclic voltammetry and compared to the previously reported electrochemical 
parameters for [Cu(L
1
)(CH3OH)] [36] (Figure 3.33). The cyclic voltammograms (CVs) 
show reversible one-electron redox couples with E1/2 = –1099 mV versus Fc/Fc
+
 and ΔE 
= 77 mV for [Cu(HL
2
)]2(ClO4)4, and E1/2 = –438 mV versus Fc/Fc
+
 and ΔE = 64 mV for 
[Cu(L
3
)](ClO4)2. The CV of [Cu(HL
2
)]2(ClO4)4 is complicated by a small reduction 
feature immediately before the Epc peak that disappears on successive scans (this 
unusual redox behavior is undergoing further study). The CV in Figure 3.33 is therefore 
the second scan, and the full first-scan CV of [Cu(HL
2










)]2(ClO4)4 (red) and [Cu(L
3
)](ClO4)2 (green), (scan rate = 100 mV s
–1
; 
0.1 M TBAPF6 supporting electrolyte). 
 
 
Figure 3.34. Cyclic voltammogram of a 1.5 mM CH3CN solution of [Cu(HL
2
)]2(ClO4)4 
(vs Ag/AgCl; scan rate = 100 mV s
–1
; 0.15 M TBAPF6 supporting electrolyte). 
Ferrocene was added as an internal standard (ferrocene/ferrocenium couple is centered 
around 500 mV). 
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Additional redox features in the CV are most likely due to some dimeric species. 
The redox couples, which were measured in CH3CN, were assigned to the Cu(II)/Cu(I) 
pair. In contrast, the previously synthesized complex [Cu(L
1
)(CH3OH)] exhibits its 
redox couple, which was measured in CH2Cl2, at E1/2 = –1585 mV and ΔE = 136 mV. 
The CV for [Cu(L
1
)(CH3OH)] in CH3CN was measured and the E1/2 was slightly lower 
than it was in CH2Cl2, with E1/2 = –1489 mV and ΔE = 93 mV. The potential needed to 
reduce the copper(II) ion is most negative for the bis(phenol)bis(imine), 
[Cu(L
1
)(CH3OH)], followed by the hybrid bis(imine) [Cu(HL
2
)]2(ClO4)4, and finally the 
most positive for the bis(pyridyl)bis(imine) [Cu(L
3
)](ClO4)2, all differing by about half 
of a volt. This trend can be explained by the electronic nature of the ligands. H2L
1
, 




, stabilizes the copper ion in the 
higher oxidation state and disfavors reduction of the copper(II) ion. On the other 
extreme, the neutral L
3
 ligand is the least electron donating ligand, which results in 
favorable acceptance of an electron by the metal ion to form a cuprous species and a 




Table 3.3. Electrochemical data for complexes presented in this work and literature 
complexes containing similar ligand sets.
a
 




CH2Cl2 –1.585 136 0.99 [36] 
[Cu(L
1




DMF –1.300 325 — [49] 
[Cu(HL
2




DMF –0.932 280 — [49] 
[Cu(L
3
)](ClO4)2 CH3CN –0.438 64 1.06 this work 
Nakahara [Cu(N4)] 
complex 
DMF –0.550 — — [28] 
McMillin [Cu(N4)] 
complex 
CH3CN –0.526 150 — [49] 
a
All potentials referenced to the Fc/Fc
+
 redox couple. CVs for solutions of complexes 
presented in this work (1.0 mM) were recorded using a glassy carbon electrode with 
scan rates of 100 mV s
–1
, and with 0.1 M TBAPF6 supporting electrolyte.  
 
 The same trend with similar absolute redox potentials for the Cu(II)/(I) couple 
was observed on related Cu(II) complexes by McMillin and coworkers [49]. In their 
study, copper(II) complexes of the Schiff bases N,N’-bis(salicylidene)propane-1,3-
propanediamine (N2O2 donor), N-(salicylidene)-N’-(2-pyridylaldene)-1,3-
propanediamine (N3O donor) and N,N’-bis(2-pyridylaldene)-1,3-propanediamine (N4 
donor) were prepared and the copper-centered redox couple determined through cyclic 
voltammetry. For comparison with our data (see Table 3.3) these potentials were 
corrected to the ferrocene/ferrocenium reference (Fc = 0.312 V vs. SSCE) [50]. 
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 The difference in potential between our N2O2-donor complex, 
[Cu(L
1
)(CH3OH)], and the copper(II) complex with McMillin’s ligand [49] is 285 mV. 
For the N3O set, despite the fact that our complex has a ClO4
–
 as the counterion while 
McMillin’s complex has a NO3
–
 counterion, the potentials are less than 100 mV 
different. Similarly, the redox potentials for the N4 complexes are very similar. The N4 
copper(II) complex of N,N’-bis(2-pyridylaldene)-1,3-propanediamine was synthesized 
and characterized by Nakahara as well [28]. The redox potential for their complex was 
measured against SCE, and in order to compare to our complex it was corrected to be 
versus ferrocene/ferrocenium (Fc = 0.470 V vs. SCE in DMF, [NBu4][ClO4]) [51]. 
Nakahara and coworkers’ reported electrochemistry matches nicely with McMillin’s, 
even though it was measured in a different solvent. The relatively minor differences 
ranging from 100 to 285 mV between our complexes and ones in the literature may be 
due to the differences in substitution of the propanediamine backbone. In general, it is 
difficult to compare redox potentials directly due to errors in conversion to different 
references/electrodes and systems, but the overall trends are in good agreement. 
 
3.8 Conclusion 










, respectively. A strategy for the synthesis of the asymmetric ligand (HL
2
) was 
successfully followed to produce high yields of HL
2
 rather than the common symmetric 
analogues. The stepwise condensation reaction, using one equivalent of 2-
pyridinecarboxaldehyde first, yielded in high purity of L
4
, which can then be further 
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reacted with another equivalent of an aldehyde; here 2-hydroxybenzaldehyde was used 
to obtain HL
2





) was studied and the conformation of the 





)](ClO4)2 were compared with our previously synthesized copper(II) 
complex, [Cu(L
1
)(CH3OH)], which contains related tetradentate Schiff base ligand 
H2L
1
. Structurally, all three copper complexes are very similar, with the ligand 





), which is deprotonated at the phenol group, 
coordinates through the two imine N atoms and two phenolate O atoms. 
[Cu(HL
2
)]2(ClO4)4 is coordinated by one pyridyl and two imine N atoms, and one 
phenolate O atom, also in the equatorial plane of the square pyramid. While the axial 
ligand in [Cu(L
1
)(CH3OH)] is a coordinated methanol molecule, a bridging phenolate O 
atom sits in the axial position of [Cu(HL
2
)]2(ClO4)4, forming a dimer. [Cu(L
3
)](ClO4)2 
is coordinated by two pyridyl and two imine N atoms in the equatorial plane, having 
weakly coordinated perchlorate anions in the axial positions. The ligands in all three 
complexes do not coordinate through the pyridine nitrogen of the ligand backbone. The 
inability of the pyridyl group from the ligand backbone to coordinate is likely due to 
steric and geometric constraints of the rigid imine skeletons of the ligands. The 
electrochemical properties of all three copper complexes were probed by cyclic 
voltammetry, showing a correlation of the electronic properties of the ligands to the 





 ligand in [Cu(L
1
)(CH3OH)] with its N2O2 donor atom set highly favors the +2 
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oxidation state and has the most negative redox potential. The neutral L
3 
ligand with its 
N4 donor atom set has a redox potential that is more than a volt more positive, while the 
mixed ligand HL
2
 with its N3O donor atom set is midway between the other two. The 
electrochemical trends observed for the three copper complexes presented here conform 




3.9.1 General Procedures  
 Unless otherwise stated, all reagents were used as received from commercial 
sources. 2-methyl-2-(pyridine-2-yl)propane-1,3-diamine (ppda) was synthesized 





synthesized according to the published procedures [36]. Solvents used were doubly 
purified using alumina columns in a MBraun solvent purification system (MB-SPS). 
Infrared spectra were measured from 4000 to 400 cm
–1
 as KBr pellets on a BIO-RAD 
FTS 155 FTIR spectrometer. 
1
H NMR spectra were measured using a Varian 300 MHz 
instrument using solvent (CHCl3) as an internal standard. Mass spectra were measured 
on a Q-TOF quadrupole time-of-flight mass spectrometer (Micromass, Manchester, 
U.K.) equipped with a Z-spray electrospray ionization (ESI) source. Elemental analyses 
were performed by Atlantic Microlab, Norcross, GA. UV-visible spectra were measured 
using a Shimadzu UV2401PC spectrophotometer in the range 250 to 900 nm on 
solutions ranging in concentration from 1.0 x 10
–3
 M to 1.0 x 10
–4
 M. Cyclic 
voltammetry experiments were performed using a BAS 50W potentiometer and a 
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standard three-electrode cell with a glassy-carbon working electrode, a Pt-wire auxiliary 
electrode, and an Ag/AgCl pseudo-reference electrode under an inert atmosphere at 
room temperature. X-band EPR spectra of the complexes were recorded at 77K using a 
Bruker EMX spectrometer. Solution magnetic susceptibilities were measured at 294K 
by the Evans method [53]. 
 
 Caution! Perchlorate salts of metal complexes with the organic ligands are 
potentially explosive. Although no difficulty was encountered during the syntheses 
described herein, they should be prepared in small amounts and handled with caution. 
 
3.9.2 Synthesis of HL
2
 
 2-Pyridinecarboxaldehyde (0.127g, 1.15 mmol) was added dropwise to a 
solution of ppda (0.190 g, 1.15 mmol) in CH3OH (5 mL). The resulting yellow solution 
was heated to reflux the solvent overnight, causing a color change to light orange. The 
solvent was removed in vacuo to give L
4





, 293K) δ 1.02–1.44 (m, 3H), 2.89–4.51 (m, 4H), 4.47–4.54 (m, 
1H), 7.18–7.90 (m, 6H), 8.27-8.62 (m, 2H). Crude L
4
 was redissolved in CH3OH (5 
mL) without further purification, and 2-hydroxybenzaldehyde (0.136 g, 1.11 mmol) was 
added. While refluxing overnight the solution turned light green. The solvent was 
removed in vacuo, yielding HL
2
 as a highly viscous orange oil (0.400 g). The oil was 
kept under nitrogen and solidified after several months. According to NMR 
spectroscopy the composition of the ligand did not change upon solidification. 
1
H NMR 
(300 MHz, CDCl3, 293K) δ 1.54 (m, 3H), 3.95–4.30 (m, 4H), 6.78–6.93 (m, 2H), 7.05–
148 
7.43 (m, 5H), 7.55–7.74 (m, 2H), 7.92–7.99 (m, 1H), 8.26–8.37 (m, 2H), 8.56–8.66 (m, 









 (minor). Solutions of HL
2
 decompose within hours, probably due to hydrolysis in 
the presence of moisture. Due to the highly viscous, sticky nature of the ligand, no 
elemental analysis was performed. Purification was achieved through complex 
formation with copper(II) ions. 
 
3.9.3 Synthesis of L
3
 
 2-Pyridinecarboxaldehyde (0.363g, 3.39 mmol) was added dropwise to a 
solution of ppda (0.280 g, 1.69 mmol) in CH3OH (5 mL). The resulting yellow solution 
was heated to reflux the solvent overnight, causing a color change to light orange. The 
solvent was removed in vacuo to give the ligand as a highly viscous dark orange oil 
(0.575 g). 
1
H NMR (300 MHz, CDCl3, 293K) δ 1.55 (s, 3H), 4.12–4.24 (m, 4H), 7.05–
7.11 (m, 1H), 7.24–7.30 (m, 2H), 7.37–7.42 (m, 1H), 7.55–7.62 (m, 1H), 7.64–7.72 (m, 









. Solutions of L
3
 decompose within hours, probably 
due to hydrolysis in the presence of moisture. Due to the highly viscous, sticky nature 
of the ligand, no elemental analysis was performed. Purification was achieved through 
complex formation with copper(II) ions. 
 
3.9.4 Synthesis of [Cu(HL
2
)]2(ClO4)4 
 Cu(ClO4)2·6H2O (0.220 g, 0.586 mmol) dissolved in methanol (1 mL) was 
added to a solution of ligand HL
2
 (0.210 g, 0.586 mmol) in CH3OH (10 mL). The 
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resulting dark green solution was stirred overnight at room temperature to yield an 
olive-green precipitate which was isolated by filtration, washed with methanol and 
diethylether (0.200 g, 53%). Anal. Calcd for [Cu(HL
2
)]2(ClO4)4·2H2O, powder, 
C44H48Cl4Cu2N8O20: C, 41.36; H, 3.79; N, 8.77. Found: C, 41.47; H, 3.51; N, 8.83. X-
ray quality crystals were obtained from Et2O diffusion into a solution of 
[Cu(HL
2
)]2(ClO4)4 in methanol/acetonitrile. Anal. Calcd for [Cu(HL
2
)]2(ClO4)4, 
crystals, C44H44Cl4Cu2N8O18: C, 42.56; H, 3.57; N, 9.02. Found: C, 42.08; H, 3.86; N, 




)]: 243 (18,300), 272 (15,600), 369 
(5,470), 573 (128). EPR (9.468 GHz, mod. amp. 25.0 G, CH3CN, 77K): g|| = 2.19, g⊥ = 
2.06, and A|| = 205 G. EPR (9.466 GHz, mod. amp. 25.0 G, CH3OH, 77K): g||(1) = 2.22, 
g⊥(1) = 2.04, and A||(1) = 190 G; g||(2) = 2.31, g⊥(2) = 2.04, and A||(2) = 200 G. FTIR 
(KBr): 2364, 2343, 1616, 1537, 1468, 1448, 1402, 1328, 1301, 1106, 1089, 1030, 964, 
780, 768, 624, 533, 508, 417 cm
–1









. Solid state magnetic moment (MSB-Auto, 4.5 kG, 
22.0 °C): 4.4 µB. Solution magnetic moment (Evans method, 20.9 °C, 16.3 x 10
–3
 M, 
acetonitrile-d3): 1.76 µB. 
 
3.9.5 Synthesis of [Cu(L
3
)](ClO4)2 
 2-Pyridinecarboxaldehyde (0.027 g, 0.254 mmol) was added dropwise to a 
solution of hexahydropyrimidine (0.065 g, 0.254 mmol) in CH3OH (5 mL) and the 
reaction mixture heated to reflux the solvent for 3 hours. After cooling to room 
temperature Cu(ClO4)·6H2O (0.094 g, 0.254 mmol) in methanol (1 mL) was added. The 
resulting turquoise solution was stirred overnight at room temperature to yield a light 
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blue precipitate which was isolated by filtration, and washed with methanol, 
diethylether and pentane (0.120 g, 78 %). X-ray quality crystals were obtained from 
Et2O diffusion into a solution of [Cu(L
3
)](ClO4)2 in acetonitrile. Anal. Calcd for 
C21H21Cl2CuN5O8: C, 41.63; H, 3.49; N, 11.56. Found: C, 41.89; H, 3.54; N, 11.64. 




)]: 281 (15,900), 661 (117). EPR (9.441 GHz, 
mod. amp. 25.0 G, CH3CN, 77K): g|| = 2.19, g⊥ = 2.07 and A|| = 185 G. FTIR (KBr): 
2364, 2343, 1653, 1602, 1564, 1475, 1429, 1311, 1267, 1230, 1121, 1090, 1023, 981, 
954, 787, 760, 671, 622, 502, 420 cm
–1





Solid state magnetic moment (MSB-Auto, 4.5 kG, 22.0 °C): 3.5 µB. Solution magnetic 
moment (Evans method, 20.9 °C, 16.8 x 10
–3
 M, acetonitrile-d3): 1.75 µB. 
 
3.9.6 X-ray Crystal Structure Determination 




)](ClO4)2 were collected using a 
diffractometer with a Bruker APEX ccd area detector [54, 55]. Data were collected 
using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The samples were 
cooled to 100(2) K. Cell parameters were determined from a non-linear least squares fit 
of the data. The data were corrected for absorption by the semi-empirical method [56]. 
The structures were solved by direct methods and refined by full-matrix least-squares 
methods on F
2 
[57, 58]. Hydrogen atom positions of hydrogens bonded to carbons were 
initially determined by geometry and refined by a riding model. Hydrogens bonded to 
nitrogens or oxygens were located on a difference map, and their positions were refined 
independently. Non-hydrogen atoms were refined with anisotropic displacement 
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parameters. Hydrogen atom displacement parameters were set to 1.2 (1.5 for methyl) 
times the displacement parameters of the bonded atoms.  
 










formula C46H52Cl4Cu2N8O20 C21H21Cl2CuN5O8 
fw 1305.84 605.87 
Crystal system Monoclinic Triclinic 
Space group C2/c P–1 
a (Å) 20.587(12) 9.183(4) 
b (Å) 12.266(7) 10.365(4) 
c (Å)  21.779(12) 12.064(5) 
α (deg) 90 88.416(8) 
β (deg) 110.162(16) 84.424(10) 
γ (deg) 90 85.125(12) 
V (Å
3
) 5163(5) 1138.5(8) 






) 1.119 0.71073 
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4.1.1 Blue Copper Proteins and Their Properties 
 Blue copper (BC) proteins, also called cupredoxins, are a class of electron 
transfer proteins which are found in a variety of biological systems, ranging from 
bacteria to humans [1]. These proteins are involved in photosynthesis (plastocyanin is 
responsible for electron transfer from cytochrome f to photosystem I) [2]; lignin 
synthesis (performed by laccase) [3]; respiration (rusticyanin acts as an electron shuttle 
between cytochromes) [4, 5]; and in reduction of nitrite in nitrite reductase (azurin) [6, 
7]. In common for all BC proteins is a mononuclear copper site, where the copper ion 
cycles between the cupric and cuprous oxidation states. Ligation of the copper ion is 
accomplished through two histidines and one cysteine in the equatorial plane (see 
trigonal planar coordination geometry for laccase).  
Figure 4.1. Geometries around the copper ion for different kinds of blue copper 
proteins: trigonal planar (laccase), tetrahedral (stellacyanin), trigonal pyramidal 
(rusticyanin, plastocyanin, pseudoazurin), trigonal bipyramidal (azurin). 
 
A fourth ligand can be present (either methionine, as in plastocyanine, or 
glutamine as in stellacyanin, to yield strained four-coordinated geometries [8]). Azurins 
are trigonal bipyramidal in structure with methionine and glycine in the axial positions. 
A schematic depiction of the possible geometries of BC proteins is shown in Figure 4.1 
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and Table 4.1 shows a summary of BC protein geometries from crystal strcuctures and 
their redox potentials.  
 
Table 4.1. Coordination and redoxpotential of Cu(II) in blue proteins. Table is adapted 
from reference [9]. 
 
 
The first crystal structure of a BC protein, namely plastocyanin (PC), was 
presented by Freeman [2, 10]. A representation of the protein structure and the 
geometric structure of the active site of PC is shown in Figure 4.2. The copper ion is 
coordinated via a N2S2 donor manifold from two histidines, one cysteine and 
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methionine and results in distorted tetrahedral coordination geometry around the metal 
ion.  
 
Figure 4.2. Crystal structure of plastocyanin and an expanded view of the geometric 
and electronic structure of the active site. Figure is adapted from reference [11]. 
 
In the following section the terms “rack state” and “entatic” will be introduced, 
which will help in understanding why blue copper proteins are extremely evolved 
electron mediators with fast electron transfer kinetics. Malmström introduced the 
concept of “rack-induced bonding” for the first time in 1964 [12]. The idea is that small 
ligands, when coordinating a metal ion, are fairly flexible and therefore will always 
arrange around the ion in a way that results in preferred geometry. In a protein, on the 
other hand, there are cooperative effects from a large number of weak interactions, 
which all together stabilize the tertiary structure of the protein resulting in little 
flexibilty and geometrical changes within the binding site for the metal ion. Vallee and 
Williams [13, 14] intoduced the term “entatic state” to the literature in 1952 and 
onwards. In the context of BC, entatic simply means that the copper ion is forced into 
an unusual geometric state. The strain forced upon the metal ion allows for unusual 
162 
properties like high reduction potentials, fast electron transfer and distinct EPR 
properties. These anomalous properties will be discussed in the following sections. 
 First normal copper complexes will be considered. As already discussed in 
Chapter 3, in synthetic copper complexes there is an energetically favorable geometry 
for Cu(II) being square planar and Cu(I) being mostly tetrahedral (see Figure 4.3). 
Strained geometries would decrease the stabilty for a particular oxidation state and as 
visualized below, an intermediate geometry between square planar and tetrahedral 
should allow for easier access of both oxidation states. 
 
Figure 4.3. Schematic depiction of the favorable geometry for Cu(I) and Cu(II). 
 
 In BC proteins, here PC shown in Figure 4.4, the geometrical changes upon 
reduction or oxidation of the metal ion are minimal. This allows for minimal 
reorganization energies (see Marcus theory [15, 16]) upon redox change, and therefore 
causes higher (or more positive) reduction potentials within the protein compared to 
normal copper complexes.  
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Figure 4.4. Geometrical changes of the active site in PC upon change in oxidation 
states. Figure is adapted from reference [17]. 
 













 it was estimated to be 






 [18]. This is again a measure of low reorganization 
energies in BC proteins, whereas with flexible ligands higher geometrical changes and 
greater energy barriers have to be overcome for change in redox state. 
When first discovered, researchers were curious about the intense blue color of 
BC proteins in the oxidized state, which they are named after. The color is caused by a 
band at around 600 nm (or ~16 000 cm
–1





(see Figure 4.5 B). This band is assigned as a ligand to metal charge transfer from the 
cysteine-sulfur to the Cu(II) ion [19]. This is a very unique feature of BC proteins (and 
not seen in normal copper complexes; see Figure 4.5 B with comparison). In tetragonal 




) d-d transitions expected 
in this region. 
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Figure 4.5. B) UV-Vis spectrum of normal and blue copper, C) EPR spectrum of 
plastocyanin (top) and D4h [CuCl4]
2–
 (bottom). Figure is adapted from reference [11, 
20]. 
 
EPR spectra are shown for normal and BC proteins in Figure 4.5 C. While 









) [20]. In 1960, the unusually 
small hyperfine coupling constants were believed to be caused by delocalization of the 
unpaired electron [21]. There are three components, namely Fermi contact (AF, negative 
value), the spin dipolar term (AS, negative value), and the orbital dipolar term (AL, 
positive value), which all together contribute to the overall metal hyperfine coupling A. 
The Fermi contact is associated with unpaired electron spin density at the nucleus, e.g. 
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 electron spin polarizing the 1s, 2s and 3s 
metal core electrons. The spin dipolar term expresses the interaction of the free electron 
averaged over the shape of the 3d-orbital with the nuclear spin of the metal ion. The 
orbital dipolar term involves the orbital angular momentum, which is derived from spin-
orbit mixing; or simply said it is dependent on the coordination geometry and therefore 
the ligand field around the metal [22]. In BC proteins, the SOMO (singly occupied 
molecular orbital, or the orbital that is occupied by the unpaired electron) is delocalized 
over the thiolate sulfur atom, which reduces AF and AS, and therefore results in a small 
hyperfine constant. Normal copper complexes can have small a hyperfine coupling due 
to distortion because it results in a larger AL [23].  
 
4.1.2 Strained Coordination Compounds in Catalysis 
 Strain was shown to influence the properties of metal complexes in proteins, as 
discussed in section 4.1.1. In this section the focus will lie on synthetic coordination 
compounds and the effect of strain onto catalytic properties of the metal complex will 
be discussed. Comba has nicely reviewed the properties of blue copper proteins and 
brought them into relationship with synthetic catalysis. In general, rigid ligands can be 
used to cause strained geometries in a metal complex which will influence 
thermodynamic, kinetic and electronic properties [24]. To the best of my knowledge 
there are only a few examples [25-27] of strained metal complexes reported, where the 




CuOiPr complex was shown to be highly efficient in lactide 
polymerization due to strained coordination geometry [28]. The synthesis of the 
catalyst, compound 2, and steps in lactide polymerization are shown in Scheme 4.1.  
 
Scheme 4.1. Synthesis of  (nacnac
Bn
CuOiPr)2 and lactide polymerization. Figure is 




CuOiPr)2, was isolated and structurally characterized 
using X-ray diffraction, which revealed that the coordination geometry around the 
copper ion is distorted square planar. Once lactide is added to the dimer, polymerization 
starts without an induction period and a monomer is believed to be the active species 
(see species 3 in Scheme 4.1). Due to steric hindrance (geometrical distortion of the 
complex), the authors believe that intermediate 3 is destabilized and polymerization is 
initiated.  
 Another example recently introduced to the literature, shows activation of an 




Figure 4.6. Highly strained platinum complex. Figure is adapted from reference [29]. 
 
A crystal structure of the platinum complex, schematically shown in Figure 4.6, 
verifies the distorted square planar geometry around the platinum ion. The authors 
hypothesize that olefin coordination is accelerated due to the highly strained Pt(II) ion 
which enhances reactivity. It was shown that this catalyst performs intramolecular 
enantioselective Friedel-Crafts alkylation of indoles.   
 
4.2 Introduction 
Salen-type ligands have been used widely as ligands in metal catalysis, mostly 
because they are fairly simple to synthesize and easily variable in structure and 
electronics by the use of different building blocks (amine or aldehyde). A broad 
background on the synthesis of Schiff base type ligands and complexes is presented in 
Chapter 3. Here, the focus will be on a special class of amines that can be used as an 
asymmetric Schiff base precursor. Previous work done in the group of Dr. Glatzhofer 
showed that the mono- or diamino substituted [2.2]paracyclophane (see Figure 4.7) can 
be used as the amine building block for Schiff base ligands and that the resulting 
copper(II) complexes have good activity in catalysis.  
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Figure 4.7. Structures of mono- and diamino[2.2]paracyclophane. 
 
Masterson reported that copper(II) complexes of Schiff base ligands derived 
from amino-[2.2]paracyclophane can be used in asymmetric cyclopropanation reactions 
[30-32]. In his earlier work it was shown that ligands A and B, see Figure 4.8, can 
perform enantioselective cyclopropanation on stilbene and styrene derived substrates 
[30, 31]. Ligand B was observed to be more enantioselective and even more efficient 
than the ligand introduced by Nozaki [33]. In a recent publication Masterson et al. have 
presented work with ligand C and it was shown that 95% ee can be achieved in 
enantioselective cyclopropanations.  
 
Figure 4.8. Ligands by Masterson used for cycloproponation reactions with comparison 
to Nozaki’s ligand. 
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Morvant has shown that pseudo-ortho-4,16-diamino[2.2]paracyclophane (see 
structure in Figure 4.10) in the presence of copper(II) ions can also be used for 
cyclopropanation reactions [34]. He reported the synthesis of the copper(II) complex 
and performed initial experiments on catalytic cyclopropanation. Little activity was 
observed using trans-4,4’-dimethylstilbene as the substrate. The copper(II) complex 
lacked in spectroscopic analysis and structural characterization. One of the goals of this 
work was to fully characterize the known complex and draw conclusions on the 
complexes reactivity in the cyclopropanation reaction. It was also desirable to 
synthesize pseudo-gem-4,15-diamino[2.2]paracyclophane and to study the Cu(II) 
complex structurally and spectroscopically in order to compare it to the ortho-
substituted version. An oxidation reaction, namely the allylic oxidation of cyclohexene 
(see Figure 4.9, and last section below) was chosen to compare the difference in 
reactivity and product distribution using the two copper complexes. Additionally, the 
question should be answered of whether it was possible to generate and isolate 
complexes with other divalent metal ions and characterize those.  
 
Figure 4.9. Allylic oxidation of cyclohexene to the most common oxidation products 
(2-cyclohexen-1-one, 2-cyclohexen-1-ol, cyclohexane oxide). 
 
In the following section, more information on the allylic oxidation will be given. 
There are many different variations of allylic oxidation known to organic chemists. 
Andrus et al. have recently published a review paper to give an overview of the most 
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common varieties [35]. In the Kharasch-Sosnovsky reaction, either Cu(I) or Cu(II) ions 
in the presence of peracids are used to generate allylic esters [36]. Another example is 
the formation of allylic alcohols using SeO2 and tert-butyl hydroperoxide by Sharpless 
and coworkers [37] or the use of mercury [38] or palladium actetate [39] to obtain 
allylic acetates. 
The allylic oxidation of alkenes with the use of only molecular oxygen as the 
oxidant is an attractive reaction as there is no other oxidant like hydrogen peroxide or a 
peracid needed. This is considered “green chemistry”. Recently, copper(II) Schiff base 
complexes have been used to catalyze the allylic oxidation of cyclohexene to give 
mainly products shown in Figure 4.9 [40-42]. As this type of reaction is proposed to go 
through a radical mechanism, the formation of other side products is possible. 
Chemoselectivity for product formation is of great importance and enones and allylic 
alcohols are the most desired products. The copper ion cyles between the cupric and 
cuprous oxidation state during the catalytic cycle [41]. 
In this study, it should be further explored whether geometrical strain in the 
Cu(II) Schiff base complex would allow for better selectivity and higher reactivity than 
the salen-type, square planar, Cu(II) complexes and initial studies should be performed. 
The idea is that geometrical strain causes a shift in redox potential which may help 
cycling between Cu(II) and Cu(I) or that strain would help in opening a coordination 
site (by dissociating one of the ligand donor atoms) for faster substrate coordination.  
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 (see structures below, Figure 4.10) were 
obtained in high purity (see NMR spectra in Appendix, Figure A.1 and A.2) upon Schiff 
base condensation of two equivalents of 2-hydroxybenzaldehyde with the 
corresponding diamine pseudo-ortho-4,16-diamino[2.2]paracyclophane or pseudo-gem-
4,15-diamino[2.2]paracyclophane, respectively. H2L
5–ortho
 was previously introduced to 
the literature by Morvant [34].  
 
Figure 4.10. Structures of novel H2L
5-gem





In a typical reaction, exact stoichiometric amounts of reactants were suspended 
in ethanol and refluxed for two hours. All starting materials dissolve within a few 
minutes of heating and the product begins to precipitate in the heat after about ten 
minutes. Bright yellow to orange-yellow powders are obtained after filtration. No 





 were characterized via 
1
H NMR, IR and UV-Vis 
spectroscopy. The proton NMR of both ligands is very clean and integration, as well as 
type of signals, match (see Appendix, Figure A.1 and A.2). Both ligands show a strong 
peak at 1614 cm
–1




 and 1281 cm
–1
 corresponding to the phenolate C–O stretch for H2L
5-gem
 and for 
H2L
5-ortho
, respectively. These assignments are consistent with previously described 
stretches of similar Schiff bases [43]. Upon coordination of a metal ion by the ligand 
these two stretching frequencies are expected to shift, which will be used later as a 
quick and cheap method to confirm complexation reactions. 
The electronic absorption spectra of the two Schiff bases are shown as an 
overlay with their corresponding copper(II) complexes in Figure 4.17. For the ligands, 
the two dominating bands in the UV (at around 230 nm and 270 nm) are assigned to π 
to π* transitions from the aromatic ring and correspond to the E2 and B band, 
respectively [44]. Each band represents the sum of the absorption of the 
[2.2]paracyclophane ring and the benzene ring from the 2-hydroxy aryl group. The band 
in the visible region at about 350 nm corresponds to the π to π* transitions from the 
C=N functional group (azomethine). This band shifts to higher wavelength upon 
coordination to a metal ion [45].  
Both ligands have a N2O2 donor set and have two easily deprotonable phenols. 
The acidic protons are highlited in red (Figure 4.10) and upon metal coordination the 
ligand is potentially dianionic. 
 








 were synthesized 
upon addition of exact stoichiometric amounts of anhydrous cupric chloride salts to a 
suspension of ligand and NEt3 as a base in methanol. To aid complex formation, the 
reaction mixtures were refluxed over night, which yielded clear brown solutions. To 
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purify the complexes, recrystallization was conducted. Therefore, methanol was 
removed under reduced pressure and the residue redissolved in toluene. Crystals 
suitable for X-ray structural analysis of both complexes were obtained upon pentane 
diffusion into the toluene solution. Schematic depictions of the copper complexes are 




], are neutral and the 
copper ion is coordinated through all atoms from the N2O2-donor manifold. The solid 
structure of the complexes will be described in Section 4.4.2.   
 






The monomeric structure for the two copper complexes is further supported by 









 is found. Elemental analysis of both complexes confirms high purity and all data was 
collected on crystalline samples. EPR and CV data are presented in Section 4.4.3 and 
4.4.4, respectively. 
Attempts to isolate other metal complexes with these two ligands were not very 
succesful. Reactions of hydrous perchlorate salts of Co(II), Ni(II), Zn(II), Fe(III) with 
and without the presence of NEt3 as a base in MeOH and CH2Cl2 did not allow for 
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complexation; even the use of anhydrous chloride salts of Fe(II), Zn(II), Ni(II), Co(II) 
and Mn(OTf)2 under anhydrous conditions in MeOH and CH2Cl2 mixtures in presence 
of NaOMe as a base did not allow for isolation of the respective metal complexes. The 
only crystals obtained upon diffusion or slow evaporation of reaction solutions were 
yellow in color. IR measurements of the latter confirmed the nature of those crystals to 
be pure ligand. Also, reaction solutions were reduced in volume and resulting 
precipitates were analyzed by IR. In all cases the evident stretches, C=N and C-O 
(phenolate), did not shift and therefore suggest that no coordination occurred. The 
ligands most likely impose too much strain and an unfavourable geometry upon 
coordination which explains the difficulties in metal complex formation. It is not 
surprising though, that copper complexes were formed readily because of copper’s 
ability to adopt strained geometries. This concept was explained earlier in the 
background and relates back to geometries found in blue copper proteins. 
However, one cobalt(II) complex was obtained upon reaction of H2L
5-gem
 and 
cobalt(II) perchlorate in the presence of NEt3 as a base in a mixture of CH2Cl2 and 
MeOH. The resulting brown-red solution produces pink-purple needle-like crystals 
upon slow evaporation. The structure was identified to be dimeric in the solid state and 








As evidenced by MS-ESI, the cobalt(II) complex could be dimeric and 
monomeric in solution. A highly intense peak is found for the dimer, and a signal that is 
about 1/10 of the dimer peak corresponds to the monomer. According to NMR, the 
complex is paramagnetic but no EPR signal was detected at 77 K or at room 
temperature. It has been shown in the literature that high spin Co(II) complexes have 
fast spin relaxation times and therefore EPR spectra need to be acquired at very low 
temperature, below 10 K [46]. The performance of such an experiment is rather 
inconvenient as liquid helium needs to be used for cooling of the sample. Spectroscopic 
and CV data will be discussed in Section 4.4.3. and 4.4.4, respectively. 
 
4.5 X-ray Crystal Structures 
According to the X-ray crystal structure of [CuL
5-gem
] (Figure 4.13), the complex 
is chiral upon coordination to copper ions and both enantiomers are found within the 
unit cell.  One of the enantiomers shows hydrogen bonding (O1S–H1S···O1B = 1.83(6) 
Å) to a trapped methanol molecule (see Figure 4.13 and Table 4.2, 4.3 and 4.6 for 
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parameters). Figure 4.14 is generated to align the enantiomeric pair as mirror images 
and help visualize the chirality of the complex. Each copper(II) ion is fourfold 
coordinated through the N2O2 donor atom set and the coordination geometry is in 
between square planar and tetrahedral. The τ4 [47] parameters are 0.39 and 0.44 for the 
two enantiomers which classifies the complex as distorted square planar. The metal to 
donor atom bonds and angles for the two complexes are similar. However, the hydrogen 
bonding of one enantiomer to the methanol solvent most likely causes slight differences 
between the two enantiomers. O1B shows a shorter Cu–O bond distance than the 
equivalent Cu–O (with O34A) bond in the other complex (1.915 Å versus 1.905 Å, 
respectively). This is not surprising because O1B will have less electron density that can 
be donated to the copper ion. This most likely causes other bond lengths to be different 
and results in slightly different donor–Cu–donor angles. 
 
Figure 4.13. Crystal structure of the enantiomeric pair of [CuL
5-gem
]. Methanol is 
hydrogen bonded to one of the structures. 
  
177 
Table 4.2. Hydrogen bonds and angles for [CuL
5-gem
] in Å and °. 
D–H···A d(D–H) d(H···A) d(D···A) <(DHA) 
O1S–H1S···O1B 0.95(6) 1.83(6) 2.764(5) 165(5) 
 
 
Figure 4.14. Enantiomeric pair of [CuL
5-gem
] aligned as mirror images. Methanol 
solvent molecule was removed for clarity. 
 
 





The crystal structure of [CuL
5-ortho
] reveals a similar distorted coordination 
environment around the copper ion (see structure in Figure 4.15 and Table 4.6 for 
parameters). Only one enantiomer is found in the unit cell. The τ4 [47] parameter is 0.50 
which indicates even more distortion than found in [CuL
5-gem
]. This value is exactly in 
between tetrahedral and square planar geometry. Copper to donor atom distances, as 
well as bond angles of [CuL
5-ortho
], are more comparable to the [CuL
5-gem
] complex that 
has no solvent interaction. Selected bond lengths and angles for both complexes are 













]    
Cu1A-O1A 1.896(3) Cu1B-O34B 1.897(3) 
Cu1A-O34A 1.905(3) Cu1B-O1B 1.915(3) 
Cu1A-N9A 1.976(4) Cu1B-N9B 1.976(4) 
Cu1A-N26A 2.016(4) Cu1B-N26B 1.986(4) 
O1A-Cu1A-O34A 83.27(14) O34B-Cu1B-O1B 85.87(13) 
O1A-Cu1A-N9A 93.49(14) O34B-Cu1B-N9B 151.35(14) 
O34A-Cu1A-N9A 152.76(14) O1B-Cu1B-N9B 92.58(14) 
O1A-Cu1A-N26A 152.39(14) O34B-Cu1B-N26B 92.44(14) 
O34A-Cu1A-N26A 90.44(14) O1B-Cu1B-N26B 146.42(15) 
N9A-Cu1A-N26A 103.80(15) N9B-Cu1B-N26B 104.05(15) 
Complex [CuL
5-ortho
]    
Cu1-O34 1.8942(18) Cu1-N26 1.991(2) 
Cu1-O1 1.9097(17) Cu1-N9 1.996(2) 
O34-Cu1-O1 90.17(7) O34-Cu1-N9 145.41(8) 
O34-Cu1-N26 93.07(8) O1-Cu1-N9 93.15(8) 




] crystallizes as a dimer (see Figure 4.16). The N2O2 set from the 
ligand is coordinating one cobalt ion and one of the phenolate arms is also bridging in 
μ-fashion between two metal centers resulting in a diamond core structure ([(CoL)2(µ-
O(Phenolate))2]). The cobalt ions are penta-coordinated in trigonal pyramidal fashion 
with τ5 [48] parameters of 0.74 and 0.79 for Co2 and Co1, respectively. There are small 
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differences between the bond length and distances of the two metal sites. If respective 
bond length were identical, there would be an inversion center in the molecule allowing 
conversion of the one site into the other. For Co1 N9A, O34A and O1B define the basal 
plane around the cobalt ion while O1A and N26A are in apical positions. Co2 shows 
O1A, O34A and N9B in equatorial positions and N26B and O1B in axial positions. 
Selected bond lengths and angles are listed in Table 4.4. 
 











Table 4.4. Selected bond lengths (Å) and angles (deg) for [CoL
5-gem
]. 
Co1-O34A 1.954(3) Co2-O34B 1.954(3) 
Co1-O1B 1.966(2) Co2-O1A 2.000(2) 
Co1-N26A 2.086(3) Co2-N9B 2.089(3) 
Co1-N9A 2.089(3) Co2-N26B 2.096(3) 
Co1-O1A 2.188(3) Co2-O1B 2.152(3) 
O34A-Co1-O1B 110.65(12) O34B-Co2-O1A 116.69(11) 
O34A-Co1-N26A 92.25(12) O34B-Co2-N9B 126.23(12) 
O1B-Co1-N26A 113.79(11) O1A-Co2-N9B 108.14(11) 
O34A-Co1-N9A 124.17(12) O34B-Co2-N26B 90.39(12) 
O1B-Co1-N9A 115.75(11) O1A-Co2-N26B 114.43(11) 
N26A-Co1-N9A 95.93(12) N9B-Co2-N26B 97.05(12) 
O34A-Co1-O1A 83.58(11) O34B-Co2-O1B 83.33(11) 
O1B-Co1-O1A 74.42(10) O1A-Co2-O1B 74.56(10) 
N26A-Co1-O1A 171.74(10) N9B-Co2-O1B 81.40(11) 
N9A-Co1-O1A 80.67(11) N26B-Co2-O1B 170.78(10) 
 
4.6 Spectroscopic Characterization of the Metal Complexes 
 High resolution electrospray mass spectrometry suggests that MeCN solutions 
of the two copper complexes are mostly monomeric with some amounts of dimeric 





















formation of the dimeric species in solution is somewhat surprising since the solid state 
182 
does not show dimeric structures. This could have been a result of the ionization 
method within the mass spectrometer. Solution magnetic moment measurements by the 
Evans method [49] in chloroform yielded in a magnetic moment of 1.53 µB/Cu for 
[Cu(L
5-ortho
)] and 1.63 µB/Cu for [Cu(L
5-gem
)]. These values are slightly lower but close 
to the spin-only value of 1.73 µB/Cu. Since the complexes were measured in 
chloroform, it is possible that a small amount of solvent evaporated during sample 
preparation and thus resulted in an increase in concentration. This automatically gives 
too low values because the concentration of a paramagnetic species is inversely 
proportional to its effective magnetic moment µB [50]. 
CH2Cl2 solutions of the cobalt(II) complex were studied by high resolution 
electrospray ionization mass spectrometry and indicate monomeric and dimeric species 




, and another 





. From MS it is not conclusive of whether the cobalt(II) complex is a 
dimer or a monomer in solution because processes within the mass spectrometer can 
cause association or dissociation. The electrochemical behavior of the cobalt complex in 
solution is discussed in Section 4.4.4. 
Utilizing IR-spectroscopy, for all three metal complexes typical shifts for the 
C=N stretch as well as C–O stretch from phenolate are seen compared to the free ligand 





 are 1614 cm
–1
 (C=N) and 1281-1283 cm
–1
 (C–O). Upon 















disappearance of the medium intensity peak at 1281-1283 cm
–1
 is observed for all three 
complexes. This stretch shifts towards higher wavenumbers [51] but it is not possible to 
exactly assign which peak corresponds to the metal complex based C–O stretch because 
multiple peaks are found in this area. 
The electronic absorption spectra of the two Schiff bases as well as the resulting 
copper(II) complexes are shown as an overlay in Figure 4.17. For the ligands the two 
dominating bands in the UV (200 to 300 nm) are assigned to π to π* transitions from the 
aromatic rings. The band in the visible region represents the π to π* transitions from the 
C=N functional group, as discussed in 4.3. 
 




 (solid black line and solid red line, 
respectively), conc. = 1.3 x 10
–5




] (dashed black 
line and dashed red line, respectively), conc. = 1.0 x 10
–5
 M and 0.6 x 10
–5
 M, 
respectively in MeCN. 
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The two copper complexes show a shift of all bands found for the ligands as 
well as additional peaks. The shoulder peak in the UV at around 240 nm is probably due 
to the metal to ligand charge transfer (MLCT) and a very weak and broad feature just 
below 500 nm could be assigned as the d–d transition within the metal ion. However, 





] show absorption in that region as well (no band 
was detected up to 1100 nm). 
   
Figure 4.18. UV-Vis spectrum of L
5-gem




] (dashed line) in 
CH2Cl2. Concentrations are 1.3 x 10
–5
 M and 0.7 x 10
–5
 M for the ligand and the cobalt 
complex, respectively. 
 
In Figure 4.18 the electronic absorption spectrum of [CoL
5-gem
] is shown as an 
overlay with the corresponding ligand. When comparing the UV-Vis bands, there is not 
much of a shift between the free ligand and the cobalt(II) complex, except broadening 
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of the band at around 350 nm. These bands are most likely arising from the ligand 
transitions as assigned for the copper complexes. The broad band at 350 nm for  
[CoL
5-gem
] could be due to an overlap of the ligand band and a CT transition from the 
complex. There are no other bands in the UV-Vis spectrum, which can be assigned to 
d–d transitions of the cobalt(II) ion. Again, as in the Cu(II) complexes, a d–d transition 
is possible to be present in the near-IR [52]. Maybe the cobalt complex dissociates in 
solution which would cause a strained geometry for the monomer. 
 EPR spectra of the two copper complexes were taken from toluene solutions at 
room temperature as well as frozen solutions at 77 K. The EPR spectra taken at room 
temperature (see Figure 4.19) show a typical isotropic signal for both complexes with 




 (60 G) for [CuL
5-ortho





 (75 G) for [CuL
5-gem
]. The splitting of the signal into four peaks is due to the 
hyperfine interaction of the unpaired electron with the copper nucleus. The isotropic 
signal is due free tumbling motion at room temperature, where enough energy is 
available to shorten and elongate metal-ligand bonds and thus the spectrum represents 
random distribution of a variety of different bond lengths [53, 54]. Since the motion of 
the atoms is faster than the EPR time scale all species are observed as the average. In 
the following the EPR spectrum of frozen glasses of the complexes will be discussed. 
Typically, at low temperature there is only limited energy available. Therefore the 
switching of bond lengths is limited and the EPR spectrum should show anisotropy due 
to preferred elongation of particular bonds [53]. 
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Figure 4.19. EPR spectra of [CuL
5-ortho
] (top spectrum) and [CuL
5-gem
] (bottom 
spectrum) solutions at room temperature in toluene. 
 
Figure 4.20 depicts the EPR spectra taken at 77 K. Again both spectra for the 
two different copper complexes look similar. This time a typical axial signal with g|| = 




 (155 G) for [CuL
5-ortho
] and g|| = 2.26, g⊥ = 




 (160 G) for [CuL
5-gem
] is observed, which suggests 
tetragonal elongation due to Jahn-Teller distortion and a dx2–y2 ground state.  
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Figure 4.20. EPR spectra of [CuL
5-ortho
] (top spectrum) and [CuL
5-gem
] (bottom 
spectrum) on frozen glasses from toluene solutions at 77 K. 
 
According to EPR studies at room temperature as well as at 77 K, both copper 
complexes show significant distortion when compared to similar square planar 
complexes. Typically a giso of around 2.10, g|| of 2.21–2.23 and an Aiso of around 85 G, 
A|| of 180 to 200 G is found for square planar salen-type complexes [55]. [Cu(salen)] in 









) at room and at low temperature, respectively [56]. It 
has been shown that lattice force can cause “artificial” strain onto the complex which is 
reduced or insignificant in the solution state [57]. A recent example that strain (here 
particularly axial compression) can be an artifact of crystal packing has been published 
by the Houser group [58]. Our EPR measurements indicate that the strain in our 
complexes is not caused by such packing forces. 
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From the crystal structures of the two copper(II) complexes it can be seen that 
[CuL
5-ortho
] is a little bit more strained towards tetrahedral geometry than [CuL
5-gem
]. 
This trend is still reflected in the EPR data. [CuL
5-ortho
] exhibits smaller A|| and Aiso, 
meaning that [CuL
5-ortho
] has more distortion towards the tetrahedral geometry.  
Electrochemical data of both complexes shows that [CuL
5-ortho
] features a more 
reversible Cu(II)/Cu(I) redox couple than [CuL
5-gem
], allowing for more reversible 
electron transfer. (Electrochemical behavior of all metal complexes will be discussed in 
detail in 4.4.4). It has been shown that there is a correlation between the electrochemical 
reversibility of the Cu(II)/Cu(I) redox couple and A (lower A values lead to more 
reversible redox couples) [54]. 
 
4.7 Electrochemical Studies 
 The redox behavior of copper(II) and cobalt(II) complexes was studied by cyclic 





with ferrocene as the internal standard, is given in Figure 4.21. There is only one redox 
feature for both copper(II) complexes observed, which is assigned to the Cu(II)/Cu(I) 




] is nearly the 
same with a value of about –1150 mV vs. Fc (see Table 4.5 for electrochemical data). 
At a scan rate of 100 mV/s the redox couple for [CuL
5-ortho
] appears reversible with ΔE 
= 66 mV and a peak current ratio of Ipa/Ipc = 0.93. On the other hand, the Cu(II)/Cu(I) 
redox couple of [CuL
5-gem
] is quasi-reversible with ΔE = 77 mV and Ipa/Ipc = 0.79. Plots 








] in MeCN at 100 
mV/s; 0.1 M TBAH as supporting electrolyte, GC as working electrode, Pt counter 
electrode and Ag as pseudo reference electrode. Ferrocene is added as an internal 
standard producing the redox couple at around +600 mV.  
 
 












] –1169 66 0.93 
[CuL
5-gem




Figure 4.22. Plot of different scan rates of 1.0 mM solution of [CuL
5-gem
] in MeCN; 
0.1 M TBAH as supporting electrolyte, GC as working electrode, Pt counter electrode 
and Ag as pseudo reference electrode. 
 
 
Figure 4.23. Plot of different scan rates of 1.0 mM solution of [CuL
5-ortho
] in MeCN; 
0.1 M TBAH as supporting electrolyte, GC as working electrode, Pt counter electrode 
and Ag as pseudo reference electrode. 
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compared to similar Schiff base complexes with N2O2 donors, the complexes reported 
herein allow for about 300–600 mV easier reduction of the copper(II) ion [55, 59]. This 
dramatic shift of the redox potentials is most likely due to the strained geometry in the 
new complexes compared to the almost square planar complexes described in the 
literature.  
 The CV for [CoL
5-gem
] is shown in Figure 4.24. The full scan from –1500 to 
+1500 mV reveals that there are no reductive features of the complex but instead 
oxidation processes are observed. There is one quasi-reversible feature at around +800 
mV, which is further studied and shown in Figure 4.25.  
 
Figure 4.24. CV of 1.0 mM solution of [CoL
5-gem
] in CH2Cl2 at 100 mV/s; 0.1 M 
TBAH as supporting electrolyte, GC as working electrode, Pt counter electrode and Ag 
as pseudo reference electrode.  
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Figure 4.25. Scan of the redox couple shown at +800 mV against the redox potential of 
Me2Fc (under same conditions as in Figure 4.24). 
 
The quasi-reversible oxidation is assigned to oxidation of Co(II) to Co(III) with 
E1/2 vs. Me2Fc = 351 mV, ΔE = 82 mV, Ipc/Ipa = 0.65. The electrochemical properties of 
the planar [Co(salen)] have been studied in DMF and DMSO (with NBu4ClO4 as the 
supporting electrolyte) and the half potential for the Co(II)/Co(III) couple was assigned 
to be 0.09 V [60] and 0.03 V [61] vs. Ag/AgCl, respectively. Depending on the solvent 
and electrolyte, the potential of Me2Fc vs. Ag/AgCl is about 0.5 V [62]. With this 
conversion, [CoL
5-gem
] is more than half a Volt harder to oxidize than the salen-based 
complex. Nishinaga et al. reported the CV of [Co(salen)] in DMF (NBu4PF6 as the 
supporting electrolyte) and the potential for the Co(II)/Co(III) couple was determined to 
be –466 mV vs. Fc, which also confirms that [CoL
5-gem
] is about 0.5 V harder to oxidize 
as [CoL
5-gem
] overlaps with the redox couple of ferrocene. The same group has 
conducted CV studies on substituted [Co(salen)] complexes (with –Cl, –NO2, –tBu, 
–Me and –OMe substituents on the aromatic ring) and the total range of E1/2 is only 
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about 100 mV wide (from –337 to –482 mV vs. Fc). This again, implies that the 
geometry in [CoL
5-gem
] most likely influences the shift in redox potential greatly.   
 
4.8 Initial Studies on Allylic Oxidation  
 Initial studies on the reactivity of allylic oxidation of cyclohexene (see 
introductory section) were conducted in two solvents using molecular oxygen as the 
oxidant (see experimental section for reaction details) and cyclohexene was freshly 





]) were evaluated on their performance for 
selectivity and catalytic enhancement of the reaction (see Figure 4.26).  
 
Figure 4.26. Product formation upon allylic oxidation of cylohexene in MeCN (all data 
is presented as a ratio to same amounts of the internal standard naphthalene). Black: no 






In the presence of molecular oxygen, cyclohexene can autooxidize to 
cyclohexene oxide, 2-cyclohexen-1-ol and 2-cyclohexen-1-one. Only small amounts of 
194 
these oxidation products are detected though as seen in Figure 4.26, black bars. In the 
presence of copper(II) ions (see red, blue and green bars in Figure 4.26) the reactivity 
can be enhanced. It appears that favorably 2-cyclohexen-1-ol (about seven times more) 
and 2-cyclohexen-1-one (about 20-fold more) are formed when copper complexes are 
present, while the amount of cyclohexene oxide created is about the same as if no 




] are more 
selective towards almost exclusively forming the main oxidation products, while “free”, 
non-ligated copper(II) ions (see chromatogram in Figure 4.27) create a variety of 
additional oxidation products such as 1,2-cyclohexanediol, cyclohex-2-ene-1,4-dione, 
2-hydroxy-cyclohexanone. 
 
Figure 4.27. Overlay of chromatograms after oxidation of cyclohexene. Red: in the 
presence of [CuL
5-gem
]; black: in the presence of CuCl2. Major oxidation products are: at 
7.0 min. cyclohexene oxide; at 8.8 min. 2-cyclohexen-1-ol; at 11.2 min. 2-cyclohexen-
1-one (internal standard naphthalene at 21.3 min.). 
 




] further enhances 
the reactivity and/or selectivity of this reaction, Cu(II)salen (which has square planar 
geometry) was prepared according to a literature procedure [63]. Unfortunately, Cu(II) 
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salen is insoluble in MeCN (most likely because of its stacked dimer structure [64]), 
and therefore reactions had to be repeated in CH2Cl2 solutions.  
 
Figure 4.28. Product formation upon allylic oxidation of cylohexene in CH2Cl2 (all data 
is presented as a ratio to same amounts of the internal standard naphthalene). Black: no 






 The reaction in methylene chloride overall suggests that copper ions do not 
enhance product formation by much (there is some increase in formation of 2-
cylohexen-1-ol by less than four-fold with any of the copper(II) complexes used). The 
square planar Cu(II)salen complex yields about the same product distribution as well as 
amounts of oxidation products as the strained complexes synthesized in this work (see 
Figure 4.28). However, it may not be fair to evaluate the effect of strain in this 
particular reaction because all copper(II) complexes perform poorly in dichloromethane, 
and unfortunately, Cu(II)salen is insoluble in acetontrile, where the allylic oxidation 








, when coordinating to copper(II) ions, 
induce strain to the coordination geometry in the complex in the solid state. EPR and 
CV measurements further indicate that strain is also present in solution. In nature, 
copper is readily found in strained geometries (see blue copper proteins) whereas other 
metals typically don’t undergo geometrical strain (here between square planar and 
tetrahedral). Thus it is not surprising that it was not possible to easily isolate any other 
metal complexes besides the ones with copper ions in the solid state. Even the cobalt(II) 
complex, which was characterized in the solid state, most likely underwent dimerization 
to prevent the strained tetradentate coordination and rather formed a trigonal 
bipyramide. In solution, the strain in the complexes may be slightly released. Therefore, 
other metals should form complexes with the two ligands in solution. In fact, this is 
indicated by the color change of metal salt addition to ligand (H2L
5-ortho
) solutions in the 
presence of base (see Figure 4.29 left). Figure 4.29 right shows the colors of the 
divalent metal salts in methanol. It seems reasonable to say that Mn, Co and Fe most 
certainly are coordinated in solution as indicated by the significant color change. 
Judging only by the change in color it can not be concluded, if Zn and Ni are 
coordinated because the ligand is yellow and Zn
2+
 does not contribute to changes in the 
visible spectrum due to the d
10
 configuration. In the case of Ni the problem of weak 
solubility occurred (see Figure 4.29 left and right, suspension with Ni). 
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Figure 4.29. Left: colored solutions of divalent metal ions with H2L
5-ortho
 (Zn, Mn, Co, 
Ni, Fe: from left to right). Right: solutions of the corresponding metal ions in methanol. 
 
Since catalysis reactions are perfomed in solution, it is not necessary to actually 
isolate the solid structures of metal complexes. These initial results are promising that 
other metal complexes can be generated in the solution state and should be tested for 





] reveal that these complexes are selective towards formation 
of 2-cyclohexen-1-ol and even more towards 2-cyclohexen-1-one. It was not possible to 
evaluate, if the strain iduced on the copper(II) ion would enhance selectivity and 
reactivity.  
 
4.10 Future Work 
Further experiments on the allylic oxidation, perhaps in a different solvent, 





], enhances reactivity and selectivity towards the oxidation products. 
Maybe a different model complex (with better solubility in MeCN), other than 
Cu(II)salen, can be used for comparison. Additionally, the new copper(II) complexes 
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should be tested as catalysts for other types of reactions. Both complexes are chiral and 
therefore could be used in asymmetric catalysis. 
Initial studies on complex formation of H2L
5-ortho
 with other divalent metal ions 
revealed that complexes, even though unable to isolate in the solid state, are formed. 
Most likely these complexes have some geometrical strain, just like the copper(II) 
complexes and for that reason it would be very interesting to test their potency as 
catalysts as well. 
4.11 Experimental 
4.11.1 General Procedures  
 Unless otherwise stated, all reagents were used as received from commercial 
sources. Pseudo-ortho-N,N’-bissalicylidene-4,16-diamino[2.2]paracyclophane was 
resynthesized according to the procedure described by Morvant [34]. The novel ligand 
pseudo-gem-N,N’-bissalicylidene-4,15-diamino[2.2]paracyclophane was prepared in 
the same way. Solvents used were doubly purified using alumina columns in a MBraun 
solvent purification system (MB-SPS). Infrared spectra were measured from 4000 to 
400 cm
–1
 as KBr pellets on a BIO-RAD FTS 155 FTIR spectrometer. 
1
H NMR spectra 
were measured using a Varian 300 MHz instrument using solvent (CHCl3) as an 
internal standard. Mass spectra were measured on a Q-TOF quadrupole time-of-flight 
mass spectrometer (Micromass, Manchester, U.K.) equipped with a Z-spray 
electrospray ionization (ESI) source. Elemental analyses were performed by Atlantic 
Microlab, Norcross, GA. UV-visible spectra were measured using a Shimadzu 
UV2401PC spectrophotometer in the range 250 to 900 nm on solutions ranging in 
concentration from 1.0 x 10
–3
 M to 1.0 x 10
–5
 M. Cyclic voltammetry experiments were 
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performed using a BAS 50W potentiometer and a standard three-electrode cell with a 
glassy-carbon working electrode, a Pt-wire auxiliary electrode, and an Ag/AgCl pseudo-
reference electrode under an inert atmosphere at room temperature. X-band EPR spectra 
of the complexes were recorded at 295 K and 77 K using a Bruker EMX spectrometer. 
Solution magnetic susceptibilities were measured at 294 K by the Evans method. GC-
MS measurements were performed on an Agilent/HP 6980 gas chromatograph with 
5973 mass spectrometric detector (Santa Clara, CA) and Alltech EC-5 column 
(GRACE, Deerfield, IL).  The inlet and transfer line were held at 200° C and 280° C, 
respectively.  With helium as the carrier gas and a split ratio of 10:1, the GC was run in 
constant flow mode with a total flow of 25.2 mL/min.  The oven temperature program 
was as follows: 35° C for 5 minutes, 2° C /minute to 60° C, 20° C/minute to 200° C, 
and hold for 5 minutes at 200° C.  The oxidation products were matched to the National 
Institute of Standards and Technology’s (NIST) 2008 library of mass spectral data. 
 
 Caution! Perchlorate salts of metal complexes with organic ligands are 
potentially explosive. Although no difficulty was encountered during the syntheses 
described herein, they should be prepared in small amounts and handled with caution. 
 
4.11.2 Synthesis of (H2L
5-ortho
) 
Salicylic aldehyde (0.212g, 1.736 mmol) was added dropwise to a solution of 
pseudo-ortho-4,16-diamino[2.2]paracyclophane (0.199 g, 0.836 mmol) in EtOH (20 
mL). The resulting yellow slurry was heated to reflux the solvent for two hours. After 
several minutes all material dissolved and 10 min. later the product started to precipitate 
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out of the solution. Once cooled to room temperature, the precipitate was collected 
through filtration. H2L
5-ortho
 was further dried under high vacuum yielding a fluffy 
bright yellow solid (0.320 g, 86 %). M.p. 228–230° C. 
1
H NMR (300 MHz, CDCl3, 
293K) δ 2.78–2.93 (m, 2H, –CH2–), 3.10–3.25 (m, 4H, –CH2–), 3.58–3.68 (m, 2H, –
CH2–), 6.46 (s, 2H, Ar–H), 6.62 (dd, 4H, Ar–H), 6.83 (t, 2H, Ar–H), 7.03 (m, 4H, Ar–
H), 7.36 (t, 2H, Ar–H), 8.25 (s, 2H, N=C–H), 13.77 (s, 2H, –OH). UV/Vis (CH2Cl2) 




)]: 231(43,200), 267 (31,100), 353 (27,100). FTIR (KBr): 2930, 
1614 (C=N), 1578, 1555, 1485, 1456, 1408, 1281 (phenolate O–C), 1204, 1150, 905, 




4.11.3 Synthesis of (H2L
5-gem
) 
Salicylic aldehyde (0.115g, 0.943 mmol) was added dropwise to a solution of 
pseudo-gem-4,15-diamino[2.2]paracyclophane (0.102 g, 0.429 mmol) in EtOH (10 
mL). The resulting yellow slurry was heated to reflux the solvent for two hours. After 
several minutes all material dissolved and 10 min. later the product started to precipitate 
out of the solution. Once cooled to room temperature, the precipitate was collected 
through filtration. H2L
5-gem
 was further dried under high vacuum yielding a fluffy 
yellow-orange solid (0.150 g, 78 %). M.p. 233–235° C. 
1
H NMR (300 MHz, CDCl3, 
293K) δ 3.02–3.20 (m, 6H, –CH2–), 3.69–3.78 (m, 2H, –CH2–),6.36 (s, 2H, Ar–H), 
6.54–6.73 (m, 8H, Ar–H), 7.08 (d, 2H, Ar–H), 7.14 (t, 2H, Ar–H), 8.27 (s, 2H, N=C–




)]: 230 (40,900), 275 
(27,500), 346 (28,000). FTIR (KBr): 2918, 2849, 1614 (C=N), 1576, 1549, 1479, 1454, 




4.11.4 Synthesis of [CuL
5-ortho
] 
Anhydrous CuCl2 (0.030 g, 0.223 mmol) dissolved in methanol (1 mL) was 
added to a suspension of ligand H2L
5-ortho
 (0.099 g, 0.222 mmol) in CH3OH (50 mL) 
and NEt3 (0.045 mg, 0.446 mmol). The resulting light green solution containing white 
solid was heated to reflux the solvent overnight to yield a brown-reddish clear solution. 
Upon cooling to room temperature, the solvent was removed under reduced pressure 
and subsequently redissolved in toluene. X-ray quality crystals (orange-brown) were 
obtained upon pentane diffusion into the filtered toluene solution (0.068 g, 61 %). Anal. 
Calcd for [CuL
5-ortho
], C30H24CuN2O2: C, 70.92; H, 4.76; N, 5.51. Found: C, 70.05; H, 




)]: 224 (47,500), 275 (32,400), 
393 (18,600). EPR (9.469 GHz, mod. amp. 25.0 G, toluene, 77 K): g|| = 2.25, g⊥ = 2.05, 
and A|| = 155 G; (9.748 GHz, mod. amp. 25.0 G, toluene, 298 K): giso = 2.13, Aiso = 60 
G. FTIR (KBr): 1609 (C=N), 1584, 1530, 1464, 1441, 1410, 1377, 1327, 1196, 1148, 
916, 887, 758, 577 cm
–1









. Solution magnetic moment (Evans method, 293.95 K, 
34.9 x 10
–3
 M, CDCl3): 1.53 µB/Cu. 
 
4.11.5 Synthesis of [CuL
5-gem
] 
Anhydrous CuCl2 (0.020 g, 0.149 mmol) dissolved in methanol (1 mL) was 
added to a suspension of ligand H2L
5-gem
 (0.063 g, 0.141 mmol) in CH3OH (50 mL) and 
NEt3 (0.020 mg, 0.287 mmol). The resulting light green solution containing white solid 
was heated to reflux the solvent overnight to yield a brown-yellow clear solution. Upon 
cooling to room temperature, the solvent was removed under reduced pressure and 
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subsequently redissolved in toluene. Crystals (yellow-brown) were obtained upon 
pentane diffusion into the filtered toluene solution (0.038 g, 53 %). Initially X-ray 
quality crystals were obtained from slow evaporation of a methanolic solution of the 
crude complex. Anal. Calcd for [CuL
5-gem
], C30H24CuN2O2: C, 70.92; H, 4.76; N, 5.51. 





(57,900), 270 (32,800), 377 (17,900). EPR (9.467 GHz, mod. amp. 25.0 G, toluene, 77 
K): g|| = 2.26, g⊥ = 2.04, and A|| = 160 G; (9.748 GHz, mod. amp. 25.0 G, toluene, 298 
K): giso = 2.12, and Aiso = 75 G. FTIR (KBr): 2928, 1607 (C=N), 1580, 1528, 1464, 
1435, 1381, 1325, 1194, 1148, 1088, 1024, 920, 895, 758, 563, 519, 449 cm
–1
. ESI-MS 









magnetic moment (Evans method, 293.95 K, 15.8 x 10
–3
 M, CDCl3): 1.63 µB/Cu. 
 
4.11.6 Synthesis of [CoL
5-gem
]2 
Co(ClO4)2·6H2O (0.015 g, 0.041 mmol) dissolved in methanol (1 mL) was 
added to a solution of ligand H2L
5-gem
 (0.015 g, 0.034 mmol) in 1:1 CH3OH:CH2Cl2 (2 
mL) and NEt3 (0.080 mg, 0.079 mmol). The resulting brown-orange solution was stirred 
for one hour at room temperature and subsequently the solvent was removed under 
reduced pressure. The crude residue was redissolved in CH2Cl2 and filtered through 
celite. About the same amount of MeOH as CH2Cl2, was added to the solution. Crystals 
(pink-purple) were obtained upon slow evaporation of the solution (0.013 g, 75 %). 




)]: 230 (56,100), 269 (30,800), 373 (14,200). 
EPR in CH2Cl2 is silent at room temperature as well as 77 K and NMR appears to be 
paramagnetic. FTIR (KBr): 2928, 1605 (C=N), 1580, 1560, 1528, 1510, 1491, 1466, 
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1439, 1412, 1321, 1300, 1192, 1152, 914, 760, 669, 662 cm
–1











4.11.7 Allylic Oxidation in MeCN 
In a typical experiment 0.006 mmol of copper(II) complex (in the case of the 
blank no copper ions were used) was dissolved in MeCN (2 mL). After all complex was 
dissolved under stirring, 100 μL (0.987 mmol, ~160 equivalents) of freshly distilled 
cyclohexene were added and the solution mixture was purged with dioxygen for 120 s. 
Subsequently the reaction vial was sealed with tape and stirred at room temperature for 
two days. Solutions were kept sealed for three more days without stirring and then 
analyzed via GC-MS. Thereafter, 500 μL of each reaction mixture was taken out and to 
that 50 μL of internal standard (naphthalene), with the same concentration for each 
sample, was added. 1 μL of this solution was injected into the GC and analyzed. The 
amounts of products in each sample are ratios of product to the internal standard and 
allow for qualitative analysis. 
 
4.11.8 Allylic Oxidation in CH2Cl2 
In a typical experiment 0.006 mmol of copper(II) complex/salt (in the case of 
the blank no copper ions were used) was dissolved in CH2Cl2 (2 mL). After all complex 
was dissolved under stirring, 50 μL (0.494 mmol, ~80 equivalents) of freshly distilled 
cyclohexene was added and the solution mixture was purged with dioxygen for 120 s. 
Subsequently the reaction vial was sealed with tape and stirred at room temperature for 
two days. 450 μL of each reaction mixture was taken out of the vial and to that 50 μL 
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(0.0005 mmol) of internal standard (naphthalene) was added. 2 μL of this solution was 
injected into the GC and analyzed. The amounts of products in each sample are ratios of 
product to the internal standard and allow for qualitative analysis. 
 
4.11.9 X-ray Crystal Structure Determination 
Single crystals of [CuL
5-gem
]2·CH3OH were obtained from slow evaporation of a 
methanolic solution of the crude complex. X-ray quality crystals of [CuL
5-ortho
] were 
obtained by diffusion of pentane into a toluene solution of [CuL
5-ortho
]. Single crystals of 
[CoL
5-gem
]2·CH2Cl2 were obtained by slow evaporation of a mixture of methanol and 
dichloromethane solution of [CoL
5-gem
]. Intensity data for all the compounds were 
collected using a diffractometer with a Bruker APEX ccd area detector [65, 66] and 
graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å). The samples were cooled to 
100(2) K. Cell parameters were determined from a non-linear least-squares fit of the 
data. The data were corrected for absorption by the semi-empirical method [67]. The 
structure was solved by direct methods and refined by full-matrix least-squares methods 
on F
2
 [68, 69]. Hydrogen atom positions of hydrogen atoms bonded to carbon atoms 
were initially determined by geometry and were refined by a riding model. Hydrogen 
atoms bonded to nitrogen or oxygen atoms were located on a difference map, and their 
positions were refined independently. The hydrogen bonded to the methanol oxygen in 
[CuL
5-gem
]2·(CH3OH) was located on a difference map, and its position was refined 
independently. Non-hydrogen atoms were refined with anisotropic displacement 
parameters. Hydrogen atom displacement parameters were set to 1.2 (1.5 for methyl) 








]2·CH2Cl2 are summarized in Table 4.6 







]2·CH2Cl2 are summarized in Table 4.3 and 4.4. Hydrogen bonds for 
[CuL
5-gem































formula 2(C30H24CuN2O2)·(CH3OH) C30H24CuN2O2 
fw 1048.15 508.05 
Crystal system Monoclinic Monoclinic 
Space group P21/n C2/c 
a (Å) 20.822(3) 21.4538(11) 
b (Å) 10.3572(14) 17.2128(8) 
c (Å)  22.863(3) 12.4304(6) 
α (deg) 90 90 
β (deg) 103.371(2) 104.502(2) 
γ (deg) 90 90 
V (Å
3
) 4796.9(11) 4444.0(4) 






) 0.945 1.016 





































Crystal system Monoclinic 
Space group P21/n 
a (Å) 10.9375(8) 
b (Å) 33.881(2) 
c (Å)  13.1335(9) 
α (deg) 90 
β (deg) 92.335(2) 
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